Next Article in Journal
Gynostemma pentaphyllum Extract Alleviates NASH in Mice: Exploration of Inflammation and Gut Microbiota
Next Article in Special Issue
Correction: Ma et al. Perioperative Enteral Immunonutrition Support for the Immune Function and Intestinal Mucosal Barrier in Gastric Cancer Patients Undergoing Gastrectomy: A Prospective Randomized Controlled Study. Nutrients 2023, 15, 4566
Previous Article in Journal
Effect of Postbiotics Derived from Lactobacillus rhamnosus PB01 (DSM 14870) on Sperm Quality: A Prospective In Vitro Study
Previous Article in Special Issue
Perioperative Enteral Immunonutrition Support for the Immune Function and Intestinal Mucosal Barrier in Gastric Cancer Patients Undergoing Gastrectomy: A Prospective Randomized Controlled Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Multimodal Prehabilitation for Patients with Crohn’s Disease Scheduled for Major Surgery: A Narrative Review

1
Department of Health Science, University of Firenze, Azienda Ospedaliero Universitaria Careggi, Largo Brambilla 3, 50139 Florence, Italy
2
Multimodal Prehabilitation Center, Azienda Ospedaliera Universitaria Careggi, Largo Brambilla 6, 50135 Florence, Italy
3
Department of Experimental and Clinical Medicine, University of Florence, Largo Brambilla 6, 50135 Florence, Italy
4
Division of Geriatric and Intensive Care Medicine, University of Florence, Azienda Ospedaliero Universitaria Careggi, Largo Brambilla 3, 50139 Florence, Italy
5
Section of Anesthesiology and Intensive Care, University of Florence, Largo Brambilla 3, 50139 Florence, Italy
6
Department for IBD and Intestinal Failure Surgery, Karolinska University Hospital, SE 177 76 Stockholm, Sweden
*
Author to whom correspondence should be addressed.
Nutrients 2024, 16(11), 1783; https://doi.org/10.3390/nu16111783
Submission received: 29 April 2024 / Revised: 25 May 2024 / Accepted: 5 June 2024 / Published: 6 June 2024

Abstract

:
Approximately 15–50% of patients with Crohn’s disease (CD) will require surgery within ten years following the diagnosis. The management of modifiable risk factors before surgery is essential to reduce postoperative complications and to promote a better postoperative recovery. Preoperative malnutrition reduced functional capacity, sarcopenia, immunosuppressive medications, anemia, and psychological distress are frequently present in CD patients. Multimodal prehabilitation consists of nutritional, functional, medical, and psychological interventions implemented before surgery, aiming at optimizing preoperative status and improve postoperative recovery. Currently, studies evaluating the effect of multimodal prehabilitation on postoperative outcomes specifically in CD are lacking. Some studies have investigated the effect of a single prehabilitation intervention, of which nutritional optimization is the most investigated. The aim of this narrative review is to present the physiologic rationale supporting multimodal surgical prehabilitation in CD patients waiting for surgery, and to describe its main components to facilitate their adoption in the preoperative standard of care.

1. Introduction

The risk of undergoing surgery in patients with Crohn’s disease (CD) is approximately 15–50% within 10 years of the diagnosis [1].
Preoperative nutritional status correlates with postoperative outcomes [2]. The aetiology of malnutrition in patients afflicted with Inflammatory Bowel Disease (IBD) encompasses multifaceted elements, including reduced dietary intake, intestinal malabsorption and protein loss, and elevated energy requisites due to systemic inflammation. However, a precise prevalence of malnutrition in this population remains unclear [3]. In particular, published rates of malnutrition in CD ranges widely, from 20% to 85% [4,5]. Therefore, it is recommended that nutritional status should be evaluated and optimized before elective surgery, whenever possible [6], and that nutritional care is ensured throughout the entire perioperative period [7].
It has been shown that preoperative nutritional status is an independent risk factor for anastomotic leakage and that preoperative nutritional therapy decreases the risk of anastomotic leakage in CD [8]. These results were also confirmed by a Cochrane review of preoperative nutritional support in patients awaiting gastrointestinal surgery for inflammatory bowel diseases and other gastrointestinal pathologies [7,9]. Furthermore, results from other meta-analyses have reported that preoperative nutrition supplementation reduces postoperative complications in patients with CD by 74% (Odds ratio = 0.26, 95% confidence interval (CI): 0.07–0.99, p < 0.001) [10]. Based on these data, the European Society of Clinical Nutrition and Metabolism (ESPEN) guidelines have recommended assessment and optimization of nutritional status, including nutritional prehabilitation, in the context of an Enhanced Recovery After Surgery (ERAS) setting (grade of recommendations: extrapolated evidence from studies, 96% strong consensus) [11].
The term “prehabilitation” characterizes a broad range of interventions that primarily seek to improve the preoperative medical, physical, nutritional, and psychological status. In some publications, the term is used to refer exclusively to interventions related to physical exercise. Here, the broader scope of the term will be discussed.
In this clinical context, nutritional interventions aim at correcting malnutrition, optimizing body composition, ensuring adequate caloric and protein intake, controlling blood glucose, providing immunonutrients, managing gastrointestinal symptoms, and overcoming barriers preventing food intake. Preliminary evidence suggests that nutritional prehabilitation is effective in increasing preoperative body weight, body mass index, and fat free mass index in both CD and ulcerative colitis patients, thus attenuating the loss of lean body mass observed postoperatively [12]. A minimum period of 7–14 days of nutritional intervention is recommended by ESPEN to positively impact postoperative outcomes. However, based on individual needs, nutritional optimization might be extended up to 6–8 weeks to better prepare the surgical patient to withstand the surgical stress and further improve postoperative outcomes [11,13]. In fact, a prolonged nutritional prehabilitation (approximately 3 months) seems to optimize the body composition of patients waiting for elective surgery and could be a useful strategy to mitigate the catabolic effect of the surgical stress response and the resulting loss of lean body mass, especially if implemented in an ERAS setting [12]. In fact, this integrated approach has been shown to facilitate the recovery of bowel function and shorten hospital stay [12]. A recent systematic review has demonstrated that a trimodal prehabilitation program, including exercise and inspiratory muscle training and nutritional and psychological support improves the preoperative functional capacity and reduces postoperative complication rates after major abdominal surgery [14]. Furthermore recent studies showed an association between physical activity, resilience, and quality of life in IBD patients [15,16]. Nevertheless, studies evaluating the efficacy of trimodal prehabilitation in CD surgical patients are currently lacking.
The aim of this narrative review is to present the physiologic rationale supporting multimodal surgical prehabilitation in CD patients waiting for surgery and describe its main components.

2. Nutritional Optimization

2.1. Nutritional Assessment and Monitoring

In CD patients, malnutrition is the result of inadequate nutritional intake, malabsorption, and increased energy expenditure due to active inflammation [11,17].
Assessing and enhancing nutritional status is a key element of surgical prehabilitation. First, nutritional screening should be performed in all patients undergoing surgery to identify patients at risk of malnutrition and those who are malnourished [11,17]. Several validated screening tools can be used to detect the risk of malnutrition in the CD population, such as the Malnutrition Universal Screening Tool (MUST), the Nutrition Risk Screening (NRS-2002), the Malnutrition Inflammation Risk Tool (MIRT), and the Saskatchewan IBD Nutrition Risk Tool (SaskIBD-NR) (Table 1). An optimal validated screening tool specific for IBD patients has not yet been identified [18]. Recently the Inflammatory Bowel Disease-Nutritional Screening tool (NS-IBD) was developed to screen IBD patients [19].
Several parameters, such as the patient clinical and social history, anthropometric measures, dietary intake, and nutritional and inflammatory biomarkers, should be evaluated during the initial nutritional assessment. This information helps to identify high-risk patients, as unintentional weight loss (UWL), body mass index (BMI), and reduction in dietary intake are strong predictors of nutritional risk [17].
An unintentional weight loss of more than 10% from baseline within the 6-month period preceding surgery has been reported in 23–54% of CD patients scheduled for intestinal resection [1]. Numerous investigations have revealed an evident association between recent UWL and surgical complications in CD patients [20,21,22,23,24]. According to a systematic review and meta-analysis, patients with CD were shown to have inadequate energy intake, especially during active disease. Furthermore, protein consumption was considerably lower than those of healthy controls, thus exposing patients to a greater nutritional risk [25]. A recent study has evaluated the dietary intake of IBD patients scheduled for surgery and compared it with the dietary reference values (DRV) derived from the Italian population (LARN), and with those indicated by the ESPEN guidelines for clinical nutrition in IBD. It was noted that IBD patients had inadequate intake of proteins, n-3 PUFA, fibre, iron, calcium, potassium, magnesium, zinc, vitamin D, and vitamin B12 with respect to the DRV. Oral intake was not influenced by gender, IBD subtype, duration of disease, and previous surgery. Moreover, it was found that in CD patients fistulizing behaviour negatively influenced oral intake [26].
BMI is a simple and fast tool used to assess nutritional status. Low preoperative BMI was associated with a higher risk of postoperative infectious complications and anastomotic leakage, reoperations, longer hospital stays, and higher mortality [27,28]. On the other hand, patients with an increased BMI are also at risk of surgical complications, especially infectious morbidity. Furthermore, obese patients are at a higher risk of complications than those who are overweight [29]. However, BMI has many limitations, as it does not provide any information about patient body composition. In fact, patients with identical BMI might have completely different lean body mass [30], and patients with different BMI might have similar lean body mass. Therefore, body composition assessment tools should be always used during nutritional assessment to identify patients with limited skeletal mass, despite normal BMI or total body weight. Notably, altered body composition is a key predictor of poor outcomes and surgical complications for CD patients [17,31].
If intestinal malabsorption is suspected, serum parameters as folic acid, vitamin B12, vitamin D, iron, zinc, magnesium, and selenium should be evaluated [32]. Patients with previous ileocecal resection with a vegan regimen or avoiding meat and dairy are at higher risk of vitamin B12 deficiency [11]. The prevalence of B12 deficiency in CD ranges from 5.6 to 38% [33]. Overall, anaemia is prevalent in up to 78% of CD patients requiring a surgical intervention and is associated with postoperative complications; furthermore, its severity is associated with poor postoperative outcomes [34,35]. The interpretation of iron serum level could be influenced by inflammatory status. In fact, in patients with IBD, anaemia of chronic disease often co-exists with iron deficiency anaemia. A case-control study showed significantly lower iron levels in CD patients compared to healthy patients, independently from their disease status (active or in remission) [36,37].
The ESPEN guidelines on clinical nutrition in IBD suggest monitoring serum calcium and 25(OH) vitamin D in patients with active disease and in those who are treated with steroids to help prevent low bone mineral density. Moreover, in geriatric CD patients, due the positive association between low vitamin D and loss of muscle mass in individuals > 65 years old [11], measuring 25(OH) vitamin D can identify patients who might benefit from Vit D supplementation to further optimize their muscle mass [38].
In IBD, the assessment and the interpretation of some serum parameters could be affected by inflammation. In fact, biochemical nutrients such as albumin may not be indicative of malnutrition in case of active CD. Serum albumin levels are lower in CD patients than in the healthy population and are inversely linked with disease activity, likely as a result of the chronic inflammatory condition [39]. Low serum albumin concentrations are associated with an increased risk of postoperative complications in CD patients [40,41], likely as a result of more severe systemic inflammation rather than an impaired nutritional state.
Although several validated tools exist to assess nutritional state in those patients identified by screening to be at risk of malnutrition, a gold standard method is still lacking. Recently, the Global Leadership Initiative on Malnutrition (GLIM) criteria were developed to address this, with the intent to present a uniform malnutrition diagnosis in clinical practice. According to GLIM criteria, the diagnosis of malnutrition is based on the presence of at least one phenotypic criterion (UWL; low BMI; reduced free fat mass (FFM)) and at least one etiologic criterion (reduced food intake or absorption; inflammation). A recent study showed that 34% of CD patients were identified as malnourished using the GLIM criteria [42]. According to the etiologic criterion, malnutrition in IBD seems linked to inflammation and malabsorption, even in absence of reduced food intake.
Sarcopenia, which is characterized by low lean muscle mass along with either poor muscle strength or low physical performance, is a common condition among CD patients. Sarcopenia can occur in both underweight and overweight IBD patients [43]. A recent systematic review of 18 studies found that the prevalence of sarcopenia among CD patients, ranges from 16 to 100%, and is higher than 50% in more than half of the included studies. This large variability might be explained by the lack of a universal definition of sarcopenia, by the anthropometric and socio-cultural heterogeneity of the population of interest, alongside with the high variability of muscle mass indices and thresholds used to identify sarcopenic patients [44]. The European Working Group on Sarcopenia in Older People (EWGSOP) identifies low muscle strength, and low muscle quantity and quality as mandatory features to diagnose sarcopenia; physical performance status is used to quantify the severity of sarcopenia [45]. Among several measures to assess body composition in IBD patients, Skeletal Muscle Mass Index (SMI) seems to be the most frequently used parameter to quantify muscle mass [31]. IBD patients might require urgent surgery, and in this clinical context it is strongly associated with postoperative complications [46]. In patients with IBD, sarcopenia has been identified as an independent predictor for both surgical complications and/or adverse outcomes, such as poor quality of life and inadequate response to medical therapy [47]. Since sarcopenia can be reversed, nutritional support and education provided by trained dietitians, together with exercise, are essential to reduce perioperative risks and optimize surgical outcomes [47].

2.2. Nutritional Intervention

Preoperative nutritional intervention in CD patients has multiple purposes: improving nutritional status, optimizing body composition, ensuring adequate caloric and protein intake, controlling blood glucose, providing immunonutrients, managing gastrointestinal symptoms, overcoming barriers preventing food intake, withstanding the catabolic impact of surgery, and supporting the energetic cost of exercise interventions in the context of a multimodal prehabilitation program. The ultimate goal is to reduce postoperative complications and facilitate surgical recovery [13,17] (Figure 1).

2.2.1. Enteral Nutrition (EN)

Whenever possible, nutritional support should be provided primarily through the enteral route administered orally or by a feeding tube [13,48]. It is recommended when patients have an inadequate oral intake or if they are unable to ensure intake levels above 50% of their recommended daily needs for more than 7 days [13].
In CD patients, preoperative EN reduces postoperative complications by 74% compared to CD patients receiving standard of care without nutritional support [10]. Two recent retrospective studies also confirmed these finding [2,49]. Abdalla et al. suggested that intra-abdominal septic complications (IASCs) and the need for defuncting stomas might be reduced with preoperative enteral nutrition [50].
Preoperative exclusive enteral nutrition (EEN) is a therapeutic regimen in CD based on the exclusive use of a nutritionally complete liquid formula as the only source of nutrition. Through mechanisms that are not yet fully explored, EEN reduces inflammation and disease activity in CD, and is recommended as the first-hand therapy in paediatric CD [11]. In the preoperative setting, it potentially enhances surgical outcomes in adults with CD [50]. A significant decrease in overall postoperative complications [51,52,53], systemic inflammation, postoperative abscesses, and anastomotic leakage [53,54] was also observed in cohort studies that examined the impact of preoperative EEN in CD patients [55,56]. In one study, preoperative EEN was effective in reducing the risk of postoperative intra-abdominal septic complications (IASCs) [54,57]. These results were subsequently confirmed by Zhu et al. [55]. One prospective trial evaluated the impact of preoperative EEN with a polymeric diet enriched with transforming growth factor-beta 2 on postoperative outcomes in both low-risk and in high-risk CD patients (defined by the presence of obstructive symptoms, steroid treatment, preoperative weight loss > 10%, and perforating CD) who underwent gastrointestinal surgery. It was found that the incidence of postoperative complication was comparable between the two groups [23]. According to one systematic review, the preoperative role of EEN in CD patients is still unclear, as good quality studies and large prospective trials are lacking [58]. However, if these preliminary and limited data are confirmed, preoperative EEN could be a beneficial nutritional strategy to reduce the risk of postoperative complications in high-risk malnourished CD patients, including early recurrence, within 6 months from surgery [53,56]. The European Crohn’s and Colitis Organization (ECCO) practice position states that pre-operative EEN in patients with stricturing or penetrating CD improves nutritional status and may reduce postoperative complications [23]. Multidisciplinary discussion about the optimal treatment duration and route of administration is advised.
A low residue diet with modified consistency or EEN via a feeding tube ending distal to the obstruction (post-stenosis), when possible, can be advised for CD patients who also have intestinal strictures or stenosis with obstructive symptoms [11].

2.2.2. Parenteral Nutrition (PN)

PN may be used to meet the recommended daily energy and protein requirements only when EN is contraindicated, ineffective, or poorly tolerated, either in combination with EN (partial parenteral nutrition PPN) or as a total parenteral nutrition (TPN). EN is generally preferred over PN due to its preservation of gut function, reduced risk of infections, cost-effectiveness, and improved long-term tolerance [59]. TPN is usually recommended in CD patients with prolonged intestinal failure [11,13]. The administration of preoperative PN frequently occurs in patients with perforating CD complicated by malnutrition [50].
There is little research on how PN affects postoperative complications in CD. One recent retrospective study compared the effect of TPN on postoperative complications between CD patients who received and did not receive TPN. Despite patients treated with TPN being more severely ill with inadequate oral intake, complications rates were comparable between the two groups [60]. A significant reduction in anastomotic leakage, postoperative complications, and non-infectious complications in CD patients receiving perioperative TPN has also been found in some studies [22,61].

2.2.3. Energy and Nutritional Requirements

ESPEN practical guidelines [8] recommends that energy delivery should be 30–35 kcal/kg/day since the energy requirements of patients with IBD are similar to those of the healthy population. If different energy needs are suspected, individual energy requirements should be determined using indirect calorimetry, especially in the context of a multimodal prehabilitation program, during which the metabolic cost of exercise should be always estimated and covered.
ESPEN practical guidelines [8] recommend a protein intake of 1.2–1.5 g/kg/d in adults with active IBD, higher than those recommended for patients without IBD. This recommendation is based on the chronically poor or unbalanced dietary intake of IBD patients, increased rates of protein turnover, gut loss of nutrients during phases of active disease with consequent malabsorption, and on the effect of disease treatments, such as corticosteroids.
In the context of a multimodal prehabilitation program, supplementing patients with whey protein might potentiate the anabolic effect resistance exercise and increase preoperative muscle mass [62]. Although this type of supplementation has not yet been studied in CD patients, oral supplementation with 20 g of whey protein has been shown to be clinically effective in improve preoperative functional walking capacity in patients with colorectal cancer [63].
In case of iron deficiency anaemia and/or anaemia of inflammatory disease, intravenous (IV) iron is likely to correct anaemia more quickly than oral supplementation as recommended by the ECCO guidelines [6].
Vitamin D combined with whey protein improves muscle function and mass in older adults, with or without exercise [64,65]. In case of deficit, vitamin D supplementation of 600–800 international units (or even higher doses) might prevent or treat low muscle mass of adult patients [66].

3. Functional Capacity and Muscle Strength Optimization

3.1. Assessment and Monitoring

Functional capacity refers to an individual’s ability to respond effectively to physiological stress, and in the surgical setting, to the prolonged increased of aerobic metabolism (oxygen consumption, VO2) observed after major surgery [67]. There are several similarities between the physiological stress, induced for example by exercise, and the stress experienced during the perioperative phase [68]. Indeed, surgical patients have an increased heart rate, cardiac workload, and oxygen utilization at the cellular level to maintain adequate tissue oxygenation and ensure organ function and healing. Postoperatively, these changes require an overall increase in oxygen consumption, and surgical patients who are unable to attain these requests have higher morbidity, mortality rates [69,70], and impaired functional recovery [71]. For example, inadequate tissue oxygenation is a critical condition that significantly affects the occurrence of anastomotic leaks after colorectal surgery [72]. Reduced preoperative functional capacity is a well-established risk factor for postoperative complications in patients undergoing colorectal surgery. IBD appears to be associated with a reduced preoperative functional capacity as compared with other colorectal diseases [73,74,75,76]. Furthermore, preliminary data have shown that patients with IBD have impaired recovery of heart rate after physiological stress, and this may further increase perioperative risks [77]. These data support the physiologic rational to employ preoperative multimodal corrective strategies, such as prehabilitation, aiming at optimizing preoperative functional [78]. However, there are currently few but encouraging data on the role of prehabilitation in patients with IBD [79]. The recommendations of the American Heart Association/American College of Cardiology (AHA/ACC) and the European Society of Cardiology/European Society of Anaesthesia (ESC/ESA) emphasize the importance of measuring functional capacity before non-cardiac surgery. In the real world, the assessment of functional capacity usually involves a subjective estimate by the physician, based, for example, on the subject’s reported ability to climb two flights of stairs (equivalent to four metabolic equivalents). Previous research has shown that oxygen utilization while climbing two flights of stairs is equivalent to four metabolic equivalents, corresponding to the oxygen consumption threshold necessary to minimize the occurrence of postoperative complications minimized [80]. However, the Measurement of Exercise Tolerance before Surgery (METS) study, a multicentre prospective cohort study, revealed that unstructured subjective assessment of functional capacity is not sensitive for identifying patients with poor preoperative cardiorespiratory and metabolic reserve (sensitivity 19.2%) and fails to accurately identify patients at high risk of postoperative morbidity [81]. Although subsequent trials have shown that unstructured subjective assessment of functional capacity might predict major cardiovascular complications and mortality, especially in a surgical population with a high cardiovascular risk, more objective methods such as the cardiopulmonary exercise test (CPET), the Six-Minute Walking Test (6MWT), and the Duke Activity Status Index (DASI) have shown better accuracy for quantifying functional capacity and predict postoperative adverse outcomes [82] (Table 2).
The CPET is widely recognized as the gold standard for measuring functional capacity. Through the measurement of peak/maximum oxygen consumption (VO2-peak, VO2-max) and anaerobic threshold (VO2-AT), it allows us to investigate the relationship between the performance of the cardiopulmonary system and the way cells utilize oxygen [81]. Previous studies have shown an association between decreased preoperative VO2-peak and VO2-AT and the risk of postoperative complications [96,97]. Although sparse evidence suggest that patients with VO2-peak less than 15 mL/kg/min or an VO2 AT less than 10–12 mL/kg/min are at high-risk of developing overall postoperative complications [81], values above these thresholds are more useful to rule out the risk of developing complications as well as in-hospital and 30-day mortality after non-cardiopulmonary surgery [98,99]. In the context of a multimodal prehabilitation program, the CPET is not only useful to stratify preoperative risk, but also to tailor the exercise prescription and to monitor the effectiveness of the prehabilitation intervention. Studies on cardiac rehabilitation have shown that CPET plays a crucial role in adapting the intensity and volume of exercises, for example through the assessment of ventilatory thresholds [85]. Similarly, CPET can be useful to verify the efficacy of exercise-prehabilitation by measuring preoperative changes of VO2-peak and/or VO2 AT [100,101]. However, as CPET requires time and dedicated resources, other measures, such as the 6MWT or the DASI, which have respectively demonstrated good and moderate predictive ability to assess functional capacity, are often preferred [102,103]. The 6MWT is a submaximal exercise test that requires participants to walk at a brisk pace continuously for a period of 6 min on a straight and level pathway 25 m in length [104]. The main objective of the test is to quantify functional capacity by measuring the distance travelled during the walking exercise. Vital parameters (oxygen saturation, heart rate, respiratory rate, and blood pressure) and perception of exertion (e.g., Borg scale) are measured before and after the test to determine the physiological and subjective response to exertion. Like the CPET, the 6MWT can provide meaningful information. First, the 6MWT has a prognostic value, as it is known that a preoperative 6-min walking distances < than 400 metres predicts postoperative complications, their severity, and impaired postoperative functional recovery after colorectal surgery [91,105]. Second, the 6MWT may be useful for exercise prescription, as it allows recording the chronotropic response to exercise and the perception of exertion using subjective methods such as the Borg scale [106,107]. Third, the 6MWT can be useful for monitoring the effectiveness of the prehabilitation treatment. It was shown, for example, that a 19-m improvement at 6MWT after a 4-week rehabilitation program was predictive of a reduced risk of postoperative complications in colorectal surgery [105]. In a sub-analysis of the METS study, the 6MWT was shown to have comparable or higher predictive power than the CPET in predicting post 1-year disability free survival, 30-day death or myocardial infarction, and 1-year mortality.
The DASI is a 12-component questionnaire with a range of values between 0 and 58.2 that has been validated to assess the physical activity level of adults [108]. Recently, the DASI has demonstrated its usefulness for the prognostic stratification of candidates for major surgery, especially for predicting cardiovascular complications. Indeed, a secondary analysis of the METS study showed that a DASI score of less than 34 identifies patients at increased risk of myocardial damage, myocardial infarction, serious complications, and the development of new disabilities [109]. In other studies, the prognostic power of the DASI for identifying patients at risk of adverse postoperative outcomes was superior to those of the 6MWT and of the CPET [110]. Although the DASI score could be used to calculate the predicted VO2-peak (predicted VO2-peak = 0.43 × DASI + 9.6) [108], the METS trial showed that a DASI score of 34 overestimates functional capacity by 2 METs, thus categorizing patients with poor functional capacity as “fit” for surgery. Moreover the formula used to estimate the VO2-peak was validated in a general population that might be functionally different from the surgical population [108]. Argillander et al. proposed the integration of different physical tests assessing both aerobic fitness and muscular strength to provide a more in-depth assessment of the patient’s physical status, and not relying solely on a single preoperative test [111]. Indeed, patients’ ability to perform the basic activities of daily living and overcome the surgical stress does not depend exclusively on functional capacity [112,113]. Indeed, various factors, including age, comorbidities, cognitive status, skeletal muscle mass and quality (sarcopenia), nutritional status, and frailty, have been shown to influence directedly or indirectly functional capacity and thus negatively impact on postoperative outcomes. Moreover, malnutrition, frailty and sarcopenia frequently coexist in the surgical population [114]. Given the complexity in evaluating preoperative functional status, and considering the increasing ageing of the IBD population, supplementing routine preoperative assessment with the evaluation of sarcopenia, malnutrition, and frailty might provide additional valuable information to better prepare IBD patients to major surgery. In fact, it is widely recognized that sarcopenia, malnutrition, and frailty have are significant risk factors for unfavourable postoperative outcomes after abdominal surgery, [115,116,117]. The gait speed, hand strength test, Timed Up and Go (TUG), 5-time chair standing test, Short Physical Performance Battery (SPPB), and Fried Phenotype Criteria are validated tools for identifying and assessing physical frailty, and most of them are also included in the current algorithm for diagnosing and establishing the severity of sarcopenia [45,118,119,120,121]. Finally, recent evidence supports the notion that frailty and sarcopenia play a crucial role as predictors of mortality, therapeutic failure, and surgical complications specifically in patients with IBD [122,123].

3.2. Exercise Intervention

Common physical interventions used in the context of a prehabilitation program are aerobic and resistance exercise training. In CD patients at high-risk of pulmonary complications, inspiratory muscle training maybe also beneficial.
As any medication prescribed requires a precise and individualized posology, exercise prescription should follow the same principles. The American College of Sports Medicine recommends using the FITT-VP (Frequency, Intensity, Timing, Type plus Volume and Progression) principles when prescribe exercise training [124,125].

3.2.1. Aerobic Exercise Training

Aerobic training, stimulating the cardiovascular system, is the most effective intervention to improve and optimize the relationship between Oxygen Delivery (DO2) and Consumption (VO2). There are two main types of aerobic training: High-Intensity Interval Training (HIIT), alternating short periods of high and low intensity workout, and Moderate Intensity Continuous Training (MICT), which consists of exercise performed continuously at a submaximal work rate. Both exercise trainings increase individual’s preoperative functional capacity [126,127,128]. Nevertheless, HIIT could better prepare functional adaptation in response to surgical stress: the time spent near the maximal peak capacity (understood as VO2-peak) and the maximal increase in stroke volume and musculoskeletal effort may be helpful to withstand surgical stress [129]. In a recent RCT, including 42 prehabilitated patients, Carli et al. compared the effects on perioperative functional capacity (measured by CPET) of two different physical exercise protocols (HIIT n = 21 versus MICT n = 21). Both MICT and HIIT equally improved preoperative functional capacity, but this benefit was maintained only in patients treated with HIIT two months after surgery [126]. Studies conducted in patients undergoing cardiac rehabilitation have shown similar results, confirming that HIIT is a more effective way to improve VO2-peak and cardiac systolic function [130]. Based on these data, HIIT seems a more effective exercise intervention for facilitating functional recovery.
Exercise intensity and protocol (HIIT or MICT) should be based on CPET-derived variables when available, ensuring an individualized and target treatment for each patient [131]. Alternatively, exercise work-rate can be setup using the Borg scale. Furthermore, each session should include both warm-up and cool-down exercises, as well as stretching [132].

3.2.2. Resistance Exercise Training

During resistance training, muscles work against a force. The goal is to increase the muscle strength reserve and the free fat mass index, severely affected by patients’ disease (inflammation and/or catabolism), neoadjuvant cancer therapies, and surgical stress.
During the prehabilitation period, it is essential to gradually increase the volume of exercise for both aerobic and resistance training. This progression can be achieved by increasing either one of the FITT variables; it is recommended to increase frequency and duration before intensity. An example of exercise prescription based on FITT-VP principles during a prehabilitation program is shown in Table 3.
The synergistic effect between physical exercise and protein supplementation facilitates muscle protein synthesis [127,133]. To avoid weight loss during prehabilitation, it is essential that the increased energy expenditure associated with exercise corresponds to an adequate caloric and protein intake.
In many patients, preoperative training must be conducted under professional supervision, especially in frail, sedentary, and non-compliant patients. Supervised exercise training seems more effective than unsupervised exercise for facilitating functional recovery [134]. Supervised training can take place either in hospital-based prehabilitation centres and/or in specialized exercise training facilities located closer to the patient’s home. It should be acknowledged that factors such as transportation, distance to the prehabilitation facility, and time dedicated to training can discourage patients participating in prehabilitation programs [135]. The effectiveness of telemedicine or digital technologies that might permit caregivers to remotely follow the adherence of the prehabilitation program need to be evaluated [136].
There are specific absolute contraindications to exercise training such as severe aortic stenosis, unstable angina, malignant arrythmia, and uncontrolled systolic blood pressure. Addressing these severe co-morbidities is the first priority in the preoperative period in these groups of patients.

3.2.3. Inspiratory Muscle Training (IMT)

IMT, which aims specifically at increasing respiratory muscle strength and endurance, has been shown to reduce postoperative atelectasis and pneumonia and shorten length of hospital stay [137]. This additional prehabilitative intervention might be particularly useful either in CD patients at high-risk of pulmonary complications (CD patients with restrictive respiratory disease ankylosing spondylitis-related) or in CD patients requiring laparotomies (especially upper gastrointestinal surgery), frequent in CD patients requiring multiple surgeries [138]. Typically, patients are asked to breath in through an inspiratory threshold-loading device at a pre-defined percentage of their maximal inspiratory strength (Pimax), 5 to 7 sessions per week, each lasting 15–30 min [137,139].

4. Psychological Distress Optimization

4.1. Assessment and Monitoring

Three out of four patients with CD undergo surgery [140]. During the preoperative period, CD patients might be worried about hospitalization, separation from family members, disabilities related to the surgery, the process of recovery [141], experiencing psychological distress, as well as anxiety and depression [141,142,143,144,145,146,147,148]. Since psychological distress may impair physical functioning before surgery and poor physical recovery after surgery [143,145,148,149,150,151,152,153], a comprehensive preoperative assessment and personalized treatment might improve outcomes (Figure 2) [148,149,153].
In the preoperative period, psychological distress can be assessed [148,153,154] via clinician- or self-reported measures [155]. Information should be collected also in areas related to psychological distress in medical ill patients, such as illness behaviour (i.e., the ways in which individuals experience, perceive, evaluate, and respond to their health status) [156,157], mental pain (i.e., a feeling state characterized by a sense of hopelessness and/or helplessness, loss of meaning, loss of self, feelings of emptiness, and loss of control or autonomy) [158], beliefs about surgery [159], and psychosomatic syndromes [160,161]. A comprehensive assessment should also consider the interplay between mental and organic diseases in terms of primary/secondary relationship [161,162]. Finally, positive features, i.e., subjective and psychological well-being [163,164], should be considered. This might demarcate major differences among CD patients who otherwise might seem to be deceptively similar since they share the same diagnosis.

4.2. Types of Intervention

Interventions aimed at reducing psychological distress in the preoperative period may help CD patients to withstand the stress of surgery, attenuate possible postoperative impairments in psychological and physical function, and accelerate the return to preoperative levels of functioning [149,153,165]. Treatment options include psychoeducation and psychotherapy based on cognitive-behavioural principles [141,148,153,166,167]. Psychoeducation may be used to provide information on the surgical procedure, treatments, expected side effects, recovery process, and functional modifications [141,153]. Cognitive behavioural therapy [168,169] may help patients to focus on the early identification and restructuring of own disruptive beliefs about surgery, which lead to psychological distress [159,168,169], promoting adaptive behaviours [141,153,167]. Intervention aimed at promoting psychological well-being, i.e., Well-Being Therapy [170], may be considered [171]. Well-Being Therapy was found to be promising in helping patients to cope with chronical medical diseases [172,173,174,175].

5. Medical Optimization

CD patients might present to surgery with several medical modifiable risk factors that, if timely identified, can be corrected.
Preoperative anaemia is associated with postoperative adverse outcomes [176]. In CD patients, iron-deficiency anaemia, frequently coexisting with anaemia of chronic inflammatory disease, can be corrected or optimized before surgery by IV iron infusion, especially considering the absorption deficit of these patients. The findings of a recent large multicentre randomized controlled trial conducted in surgical patients undergoing major non-cardiac surgery demonstrated that although variations of preoperative haemoglobin concentrations following ferric carboxymaltose infusion might be marginal, postoperatively haemoglobin concentrations continue to raise and remain significantly higher than those of patients not treated with preoperative IV iron. These data suggest that, even when preoperative time is not sufficient to significantly increase haemoglobin concentrations, preoperative anaemia should be still optimized to facilitate surgical recovery, minimize the risk of postoperative complications, and avoid unnecessary allogenic blood transfusions [177].
Similarly, impaired glucose control at the time of major surgery has been associated with postoperative infections, delayed wound healing, and cardiovascular complications [178]. Although the introduction of immunomodulating agent and biologics have significantly reduced the use of corticosteroids, frequently CD patients are still on steroids at the time of surgery, usually tapered down (<15–20 mg of prednisone/day) to prevent infectious complications [179,180]. Several important considerations are required. First, despite gradual reduction of preoperative dosages, glycaemic control of CD patients might be impaired considering the long-lasting chronic exposure to this treatment. Second, to avoid disease flare-up before surgery due to a subtherapeutic steroid dosage, surgery should be planned soon after the end of the prehabilitation period, at the lowest steroid dosage possible. Exclusive enteral nutrition has been used to limit the risk of flare-ups during the preoperative weaning of disease-modifying medications such as corticosteroids. Third, CD patients on a low-dose of steroids should continue their treatment until the morning of surgery. Whether or not administering an additional preoperative stress dose of IV hydrocortisone prevents perioperative adrenal insufficiency, especially when patients are on a low-dose of corticosteroid, remains unclear [181]. Finally, it should be acknowledged that some immunomodulating agent and biologics can affect glucose metabolism [180]. Although, to the best of our knowledge, trials demonstrating that ameliorating preoperative glycaemic control improves postoperative outcomes are lacking, multimodal prehabilitation represents an opportunity to optimize glucose metabolism, and thus minimizing the risk of postoperative complications.
There is ongoing debate regarding the importance of immunosuppressive medications in increasing perioperative risks in CD. A detailed discussion of this topic is beyond the scope of this article. In summary, there is broad consensus that the immunomodulators (azathioprine and 6-mercaptopurine) are unlikely to affect perioperative risks. In contrast, the data on TNF-alpha antagonists such as infliximab are contradictory. There are scant high-quality data on newer classes of drugs such as integrin inhibitors and Janus kinase inhibitors.

6. Duration of the Trimodal Prehabilitation Program

The duration of published multimodal prehabilitation programs ranges from 1 to 6 or more weeks [182]. Although prehabilitation studies conducted in colorectal cancer patients typically report an intervention period of 4 weeks, the minimum and optimal duration of a multimodal prehabilitation program remains to be determined. Even if surgery for CD patients is not strictly time-sensitive, and therefore the duration of the prehabilitation program could be prolonged if needed, it should be considered that by excessively postponing surgery to facilitate preoperative optimization might lead to disease flare up and/or to urgent surgery. Therefore, prehabilitation should be individualized and delivered in an optimal time window.

7. Conclusions

The physiologic rational supporting multimodal prehabilitation in patients affected by CD before major surgery is provided by several studies demonstrating the efficacy of several heterogenous unimodal interventions (nutritional optimization, medical optimization, inspiratory muscle training) in reducing postoperative complications and facilitating surgical recovery. Preoperative functional capacity and psychological status have been scarcely addressed. It is therefore plausible to hypothesize that the proven benefits of multimodal prehabilitation observed in an heterogenous surgical population undergoing major abdominal surgery, integrating medical, functional, nutritional, and psychological optimization, might be advantageous also for patients with CD. Further studies are needed to establish the efficacy of multimodal prehabilitation in this specific surgical population.

Author Contributions

Conceptualization, C.F., G.B. and F.G.; writing—original draft preparation, C.F., C.T., G.B., G.D.T., L.F., G.M., S.R., F.G., M.S. and F.C.; writing—review and editing, C.F., G.B., F.G., M.S. and F.C.; supervision, G.B., F.G., M.S., S.S. and A.N.; English revision, G.B. and F.G. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Acknowledgments

We thank Ferdinando Ficari for helping developing this manuscript by sharing his knowledge and expertise related to patients with inflammatory bowel diseases.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Regueiro, M.; Velayos, F.; Greer, J.B.; Bougatsos, C.; Chou, R.; Sultan, S.; Singh, S. American Gastroenterological Association Institute Technical Review on the Management of Crohn’s Disease After Surgical Resection. Gastroenterology 2017, 152, 277–295.e3. [Google Scholar] [CrossRef] [PubMed]
  2. Jiang, T.; Jiang, Y.; Jin, Q.; Xu, S.; Fingerhut, A.; Shi, Y.; Zheng, M.; He, Z. Role of perioperative nutritional status and enteral nutrition in predicting and preventing post-operative complications in patients with Crohn’s disease. Front. Nutr. 2022, 9, 1085037. [Google Scholar] [CrossRef] [PubMed]
  3. Massironi, S.; Viganò, C.; Palermo, A.; Pirola, L.; Mulinacci, G.; Allocca, M.; Peyrin-Biroulet, L.; Danese, S. Inflammation and malnutrition in inflammatory bowel disease. Lancet Gastroenterol. Hepatol. 2023, 8, 579–590. [Google Scholar] [CrossRef] [PubMed]
  4. Donnellan, C.F.; Yann, L.H.; Lal, S. Nutritional management of Crohn’s disease. Ther. Adv. Gastroenterol. 2013, 6, 231–242. [Google Scholar] [CrossRef] [PubMed]
  5. Goh, J.; O’morain, C.A. Nutrition and adult inflammatory bowel disease. Aliment. Pharmacol. Ther. 2003, 17, 307–320. [Google Scholar] [CrossRef] [PubMed]
  6. Sebastian, S.; Segal, J.P.; Hedin, C.; Pellino, G.; Kotze, P.G.; Adamina, M.; Campmans-Kuijpers, M.; Davies, J.; de Vries, A.C.; Casbas, A.G.; et al. ECCO Topical Review: Roadmap to Optimal Peri-Operative Care in IBD. J. Crohn’s Colitis 2023, 17, 153–169. [Google Scholar] [CrossRef] [PubMed]
  7. Grass, F.; Pache, B.; Martin, D.; Hahnloser, D.; Demartines, N.; Hübner, M. Preoperative Nutritional Conditioning of Crohn’s Patients-Systematic Review of Current Evidence and Practice. Nutrients 2017, 9, 562. [Google Scholar] [CrossRef] [PubMed]
  8. Guo, Z.; Guo, D.; Gong, J.; Zhu, W.; Zuo, L.; Sun, J.; Li, N.; Li, J. Preoperative Nutritional Therapy Reduces the Risk of Anastomotic Leakage in Patients with Crohn’s Disease Requiring Resections. Gastroenterol. Res. Pract. 2016, 2016, 5017856. [Google Scholar] [CrossRef] [PubMed]
  9. Burden, S.; Todd, C.; Hill, J.; Lal, S. Pre-operative Nutrition Support in Patients Undergoing Gastrointestinal Surgery. Cochrane Database Syst. Rev. 2012, CD008879. [Google Scholar] [CrossRef] [PubMed]
  10. Brennan, G.T.; Ha, I.; Hogan, C.; Nguyen, E.; Jamal, M.M.; Bechtold, M.L.; Nguyen, D.L. Does preoperative enteral or parenteral nutrition reduce postoperative complications in Crohn’s disease patients: A meta-analysis. Eur. J. Gastroenterol. Hepatol. 2018, 30, 997–1002. [Google Scholar] [CrossRef] [PubMed]
  11. Bischoff, S.C.; Bager, P.; Escher, J.; Forbes, A.; Hébuterne, X.; Hvas, C.L.; Joly, F.; Klek, S.; Krznaric, Z.; Ockenga, J.; et al. ESPEN guideline on Clinical Nutrition in inflammatory bowel disease. Clin. Nutr. 2023, 42, 352–379. [Google Scholar] [CrossRef] [PubMed]
  12. Fiorindi, C.; Cuffaro, F.; Piemonte, G.; Cricchio, M.; Addasi, R.; Dragoni, G.; Scaringi, S.; Nannoni, A.; Ficari, F.; Giudici, F. Effect of long-lasting nutritional prehabilitation on postoperative outcome in elective surgery for IBD. Clin. Nutr. 2021, 40, 928–935. [Google Scholar] [CrossRef] [PubMed]
  13. Weimann, A.; Braga, M.; Carli, F.; Higashiguchi, T.; Hübner, M.; Klek, S.; Laviano, A.; Ljungqvist, O.; Lobo, D.N.; Martindale, R.; et al. ESPEN guideline: Clinical nutrition in surgery. Clin. Nutr. 2017, 36, 623–650. [Google Scholar] [CrossRef] [PubMed]
  14. Jain, S.R.; Kandarpa, V.L.; Yaow, C.Y.; Tan, W.J.; Ho, L.M.; Sivarajah, S.S.; Ng, J.L.; Chong, C.X.; Aw, D.K.; Foo, F.J.; et al. The role and effect of multimodal prehabilitation before major abdominal surgery: A systemic review and meta-analysis. World J. Surg. 2023, 47, 86–102. [Google Scholar] [CrossRef]
  15. Taylor, K.; Scruggs, P.W.; Balemba, O.B.; Wiest, M.M.; Vella, C.A. Associations between physical activity, resilience, and quality of life in people with inflammatory bowel disease. Eur. J. Appl. Physiol. 2018, 118, 829–836. [Google Scholar] [CrossRef] [PubMed]
  16. Jones, K.; Naisby, J.; Baker, K.; Tew, G.A. Exercise Perceptions and Experiences in Adults with Crohn’s Disease Following a Combined Impact and Resistance Training Program: A Qualitative Study. Crohn’s Colitis 360 2023, 5, otad019. [Google Scholar] [CrossRef] [PubMed]
  17. Adamina, M.; Gerasimidis, K.; Sigall-Boneh, R.; Zmora, O.; de Buck van Overstraeten, A.; Campmans-Kuijpers, M.; Ellul, P.; Katsanos, K.; Kotze, P.G.; Noor, N.; et al. Perioperative Dietary Therapy in Inflammatory Bowel Disease. J. Crohn’s Colitis 2020, 14, 431–444. [Google Scholar] [CrossRef] [PubMed]
  18. Li, S.; Ney, M.; Eslamparast, T.; Vandermeer, B.; Ismond, K.P.; Kroeker, K.; Halloran, B.; Raman, M.; Tandon, P. Systematic review of nutrition screening and assessment in inflammatory bowel disease. World J. Gastroenterol. 2019, 25, 3823–3837. [Google Scholar] [CrossRef] [PubMed]
  19. Fiorindi, C.; Dragoni, G.; Scaringi, S.; Staderini, F.; Nannoni, A.; Ficari, F.; Giudici, F. Relationship between Nutritional Screening Tools and GLIM in Complicated IBD Requiring Surgery. Nutrients 2021, 13, 3899. [Google Scholar] [CrossRef] [PubMed]
  20. Alves, A.; Panis, Y.; Bouhnik, Y.; Pocard, M.; Vicaut, E.; Valleur, P. Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn’s disease: A multivariate analysis in 161 consecutive patients. Dis. Colon Rectum 2007, 50, 331–336. [Google Scholar] [CrossRef] [PubMed]
  21. Aydinli, H.H.; Aytac, E.; Remzi, F.H.; Bernstein, M.; Grucela, A.L. Factors Associated with Short-Term Morbidity in Patients Undergoing Colon Resection for Crohn’s Disease. J. Gastrointest. Surg. 2018, 22, 1434–1441. [Google Scholar] [CrossRef] [PubMed]
  22. Ayoub, F.; Kamel, A.Y.; Ouni, A.; Chaudhry, N.; Ader, Y.; Tan, S.; Iqbal, A.; Zimmermann, E.M.; Glover, S.C. Pre-operative total parenteral nutrition improves post-operative outcomes in a subset of Crohn’s disease patients undergoing major abdominal surgery. Gastroenterol. Rep. 2019, 7, 107–114. [Google Scholar] [CrossRef] [PubMed]
  23. Beaupel, N.; Brouquet, A.; Abdalla, S.; Carbonnel, F.; Penna, C.; Benoist, S. Preoperative oral polymeric diet enriched with transforming growth factor-beta 2 (Modulen) could decrease postoperative morbidity after surgery for complicated ileocolonic Crohn’s disease. Scand J. Gastroenterol. 2017, 52, 5–10. [Google Scholar] [CrossRef] [PubMed]
  24. Iesalnieks, I.; Hoene, M.; Bittermann, T.; Schlitt, H.J.; Hackl, C. Mechanical Bowel Preparation (MBP) Prior to Elective Colorectal Resections in Crohn’s Disease Patients. Inflamm. Bowel Dis. 2018, 24, 908–915. [Google Scholar] [CrossRef] [PubMed]
  25. Lambert, K.; Pappas, D.; Miglioretto, C.; Javadpour, A.; Reveley, H.; Frank, L.; Grimm, M.C.; Samocha-Bonet, D.; Hold, G.L. Systematic review with meta-analysis: Dietary intake in adults with inflammatory bowel disease. Aliment. Pharmacol. Ther. 2021, 54, 742–754. [Google Scholar] [CrossRef] [PubMed]
  26. Fiorindi, C.; Dragoni, G.; Alpigiano, G.; Piemonte, G.; Scaringi, S.; Staderini, F.; Nannoni, A.; Ficari, F.; Giudici, F. Nutritional adequacy in surgical IBD patients. Clin. Nutr. ESPEN 2021, 41, 198–207. [Google Scholar] [CrossRef] [PubMed]
  27. Hossne, R.S.; Sassaki, L.Y.; Baima, J.P.; Meira Júnior, J.D.; Campos, L.M. Analysis of risk factors and postoperative complications in patients with Crohn’s disease. Arq. Gastroenterol. 2018, 55, 252–257. [Google Scholar] [CrossRef] [PubMed]
  28. Zhu, Y.; Zhou, W.; Qi, W.; Liu, W.; Chen, M.; Zhu, H.; Xiang, J.; Xie, Q.; Chen, P. Body mass index is a practical preoperative nutritional index for postoperative infectious complications after intestinal resection in patients with Crohn’s disease. Medicine 2017, 96, e7113. [Google Scholar] [CrossRef]
  29. Jiang, K.; Chen, B.; Lou, D.; Zhang, M.; Shi, Y.; Dai, W.; Shen, J.; Zhou, B.; Hu, J. Systematic review and meta-analysis: Association between obesity/overweight and surgical complications in IBD. Int. J. Color. Dis. 2022, 37, 1485–1496. [Google Scholar] [CrossRef] [PubMed]
  30. Martin, L.; Birdsell, L.; MacDonald, N.; Reiman, T.; Clandinin, M.T.; McCargar, L.J.; Murphy, R.; Ghosh, S.; Sawyer, M.B.; Baracos, V.E. Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J. Clin. Oncol. 2013, 31, 1539–1547. [Google Scholar] [CrossRef] [PubMed]
  31. Tang, W.; Xie, G.; Wang, D.; Li, T.; Ren, Y.; Li, J.; Deng, J.; Li, K. Imaging-based assessment of body composition in patients with Crohn’s disease: A systematic review. Int. J. Color. Dis. 2023, 38, 126. [Google Scholar] [CrossRef] [PubMed]
  32. Maaser, C.; Sturm, A.; Vavricka, S.R.; Kucharzik, T.; Fiorino, G.; Annese, V.; Calabrese, E.; Baumgart, D.C.; Bettenworth, D.; Borralho Nunes, P.; et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. J. Crohn’s Colitis 2018, 13, 144–164K. [Google Scholar] [CrossRef] [PubMed]
  33. Duerksen, D.R.; Fallows, G.; Bernstein, C.N. Vitamin B12 malabsorption in patients with limited ileal resection. Nutrition 2006, 22, 1210–1213. [Google Scholar] [CrossRef] [PubMed]
  34. Hans, G.; Jones, N. Preoperative anaemia. Contin. Educ. Anaesth. Crit. Care Pain 2013, 13, 71–74. [Google Scholar] [CrossRef]
  35. Michailidou, M.; Nfonsam, V.N. Preoperative anemia and outcomes in patients undergoing surgery for inflammatory bowel disease. Am. J. Surg. 2018, 215, 78–81. [Google Scholar] [CrossRef] [PubMed]
  36. Krzystek-Korpacka, M.; Neubauer, K.; Berdowska, I.; Zielinski, B.; Paradowski, L.; Gamian, A. Impaired erythrocyte antioxidant defense in active inflammatory bowel disease: Impact of anemia and treatment. Inflamm. Bowel Dis. 2010, 16, 1467–1475. [Google Scholar] [CrossRef] [PubMed]
  37. Lomer, M.C.; Kodjabashia, K.; Hutchinson, C.; Greenfield, S.M.; Thompson, R.P.; Powell, J.J. Intake of dietary iron is low in patients with Crohn’s disease: A case-control study. Br. J. Nutr. 2004, 91, 141–148. [Google Scholar] [CrossRef] [PubMed]
  38. Gustafsson, U.O.; Scott, M.J.; Hubner, M.; Nygren, J.; Demartines, N.; Francis, N.; Rockall, T.A.; Young-Fadok, T.M.; Hill, A.G.; Soop, M.; et al. Guidelines for perioperative care in elective colorectal surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations: 2018. World J. Surg. 2019, 43, 659–695. [Google Scholar] [CrossRef]
  39. Su, Q.; Li, X.; Mo, W.; Yang, Z. Low serum bilirubin, albumin, and uric acid levels in patients with Crohn’s disease. Medicine 2019, 98, e15664. [Google Scholar] [CrossRef] [PubMed]
  40. Nguyen, G.C.; Du, L.; Chong, R.Y.; Jackson, T.D. Hypoalbuminaemia and Postoperative Outcomes in Inflammatory Bowel Disease: The NSQIP Surgical Cohort. J. Crohn’s Colitis 2019, 13, 1433–1438. [Google Scholar] [CrossRef] [PubMed]
  41. Ge, X.; Liu, H.; Tang, S.; Wu, Y.; Pan, Y.; Liu, W.; Qi, W.; Ye, L.; Cao, Q.; Zhou, W. Preoperative hypoalbuminemia is an independent risk factor for postoperative complications in Crohn’s disease patients with normal BMI: A cohort study. Int. J. Surg. 2020, 79, 294–299. [Google Scholar] [CrossRef] [PubMed]
  42. Fiorindi, C.; Luceri, C.; Dragoni, G.; Piemonte, G.; Scaringi, S.; Staderini, F.; Nannoni, A.; Ficari, F.; Giudici, F. GLIM Criteria for Malnutrition in Surgical IBD Patients: A Pilot Study. Nutrients 2020, 12, 2222. [Google Scholar] [CrossRef] [PubMed]
  43. Adams, D.W.; Gurwara, S.; Silver, H.J.; Horst, S.N.; Beaulieu, D.B.; Schwartz, D.A.; Seidner, D.L. Sarcopenia Is Common in Overweight Patients with Inflammatory Bowel Disease and May Predict Need for Surgery. Inflamm. Bowel Dis. 2017, 23, 1182–1186. [Google Scholar] [CrossRef] [PubMed]
  44. Potcovaru, C.G.; Filip, P.V.; Neagu, O.M.; Diaconu, L.S.; Salmen, T.; Cinteză, D.; Pantea Stoian, A.; Bobirca, F.; Berteanu, M.; Pop, C. Diagnostic Criteria and Prognostic Relevance of Sarcopenia in Patients with Inflammatory Bowel Disease-A Systematic Review. J. Clin. Med. 2023, 12, 4713. [Google Scholar] [CrossRef] [PubMed]
  45. Cruz-Jentoft, A.J.; Bahat, G.; Bauer, J.; Boirie, Y.; Bruyère, O.; Cederholm, T.; Cooper, C.; Landi, F.; Rolland, Y.; Sayer, A.A.; et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing 2019, 48, 16–31. [Google Scholar] [CrossRef] [PubMed]
  46. Ryan, E.; McNicholas, D.; Creavin, B.; Kelly, M.E.; Walsh, T.; Beddy, D. Sarcopenia and Inflammatory Bowel Disease: A Systematic Review. Inflamm. Bowel Dis. 2019, 25, 67–73. [Google Scholar] [CrossRef] [PubMed]
  47. Erős, A.; Soós, A.; Hegyi, P.; Szakács, Z.; Benke, M.; Szűcs, Á.; Hartmann, P.; Erőss, B.; Sarlós, P. Sarcopenia as an independent predictor of the surgical outcomes of patients with inflammatory bowel disease: A meta-analysis. Surg. Today 2020, 50, 1138–1150. [Google Scholar] [CrossRef] [PubMed]
  48. Stoner, P.L.; Kamel, A.; Ayoub, F.; Tan, S.; Iqbal, A.; Glover, S.C.; Zimmermann, E.M. Perioperative Care of Patients with Inflammatory Bowel Disease: Focus on Nutritional Support. Gastroenterol. Res. Pract. 2018, 2018, 7890161. [Google Scholar] [CrossRef] [PubMed]
  49. Meade, S.; Patel, K.V.; Luber, R.P.; O’Hanlon, D.; Caracostea, A.; Pavlidis, P.; Honap, S.; Anandarajah, C.; Griffin, N.; Zeki, S.; et al. A retrospective cohort study: Pre-operative oral enteral nutritional optimisation for Crohn’s disease in a UK tertiary IBD centre. Aliment. Pharmacol. Ther. 2022, 56, 646–663. [Google Scholar] [CrossRef] [PubMed]
  50. Abdalla, S.; Benoist, S.; Maggiori, L.; Zerbib, P.; Lefevre, J.H.; Denost, Q.; Germain, A.; Cotte, E.; Beyer-Berjot, L.; Corte, H.; et al. Impact of preoperative enteral nutritional support on postoperative outcome in patients with Crohn’s disease complicated by malnutrition: Results of a subgroup analysis of the nationwide cohort registry from the GETAID Chirurgie group. Color. Dis. 2021, 23, 1451–1462. [Google Scholar] [CrossRef] [PubMed]
  51. Ge, X.; Tang, S.; Yang, X.; Liu, W.; Ye, L.; Yu, W.; Xu, H.; Cao, Q.; Zhou, W.; Cai, X. The role of exclusive enteral nutrition in the preoperative optimization of laparoscopic surgery for patients with Crohn’s disease: A cohort study. Int. J. Surg. 2019, 65, 39–44. [Google Scholar] [CrossRef] [PubMed]
  52. Li, Y.; Zuo, L.; Zhu, W.; Gong, J.; Zhang, W.; Gu, L.; Guo, Z.; Cao, L.; Li, N.; Li, J. Role of exclusive enteral nutrition in the preoperative optimization of patients with Crohn’s disease following immunosuppressive therapy. Medicine 2015, 94, e478. [Google Scholar] [CrossRef] [PubMed]
  53. Wang, H.; Zuo, L.; Zhao, J.; Dong, J.; Li, Y.; Gu, L.; Gong, J.; Liu, Q.; Zhu, W. Impact of Preoperative Exclusive Enteral Nutrition on Postoperative Complications and Recurrence After Bowel Resection in Patients with Active Crohn’s Disease. World J. Surg. 2016, 40, 1993–2000. [Google Scholar] [CrossRef] [PubMed]
  54. Li, G.; Ren, J.; Wang, G.; Hu, D.; Gu, G.; Liu, S.; Ren, H.; Wu, X.; Li, J. Preoperative exclusive enteral nutrition reduces the postoperative septic complications of fistulizing Crohn’s disease. Eur. J. Clin. Nutr. 2014, 68, 441–446. [Google Scholar] [CrossRef] [PubMed]
  55. Zhu, F.; Li, Y.; Guo, Z.; Cao, L.; Feng, D.; Zhang, T.; Zhu, W.; Gong, J. Nomogram to Predict Postoperative Intra-abdominal Septic Complications After Bowel Resection and Primary Anastomosis for Crohn’s Disease. Dis. Colon Rectum 2020, 63, 629–638. [Google Scholar] [CrossRef] [PubMed]
  56. Costa-Santos, M.P.; Palmela, C.; Torres, J.; Ferreira, A.; Velho, S.; Ourô, S.; Glória, L.; Gordo, I.; Maio, R.; Cravo, M. Preoperative enteral nutrition in adults with complicated Crohn’s disease: Effect on disease outcomes and gut microbiota. Nutrition 2020, 70, 100009. [Google Scholar] [CrossRef] [PubMed]
  57. Heerasing, N.; Thompson, B.; Hendy, P.; Heap, G.A.; Walker, G.; Bethune, R.; Mansfield, S.; Calvert, C.; Kennedy, N.A.; Ahmad, T.; et al. Exclusive enteral nutrition provides an effective bridge to safer interval elective surgery for adults with Crohn’s disease. Aliment. Pharmacol. Ther. 2017, 45, 660–669. [Google Scholar] [CrossRef] [PubMed]
  58. Shariff, S.; Moran, G.; Grimes, C.; Cooney, R.M. Current Use of EEN in Pre-Operative Optimisation in Crohn’s Disease. Nutrients 2021, 13, 4389. [Google Scholar] [CrossRef]
  59. Bechtold, M.L.; Brown, P.M.; Escuro, A.; Grenda, B.; Johnston, T.; Kozeniecki, M.; Limketkai, B.N.; Nelson, K.K.; Powers, J.; Ronan, A.; et al. When is enteral nutrition indicated? J. Parenter. Enter. Nutr. 2022, 46, 1470–1496. [Google Scholar] [CrossRef] [PubMed]
  60. Traiki, T.A.B.; Alshammari, S.A.; Aljomah, N.A.; Alsalouli, M.M.; Altawil, E.S.; Abdulla, M.H.; Alhassan, N.S.; Alkhayal, K.A. The impact of preoperative total parenteral nutrition on the surgical complications of Crohn’s disease: A retrospective cohort study. Saudi J. Gastroenterol. 2022, 29, 158–163. [Google Scholar] [CrossRef] [PubMed]
  61. Jacobson, S. Early postoperative complications in patients with Crohn’s disease given and not given preoperative total parenteral nutrition. Scand. J. Gastroenterol. 2012, 47, 170–177. [Google Scholar] [CrossRef] [PubMed]
  62. Phillips, S.M. Protein requirements and supplementation in strength sports. Nutrition 2004, 20, 689–695. [Google Scholar] [CrossRef] [PubMed]
  63. Gillis, C.; Loiselle, S.E.; Fiore, J.F., Jr.; Awasthi, R.; Wykes, L.; Liberman, A.S.; Stein, B.; Charlebois, P.; Carli, F. Prehabilitation with Whey Protein Supplementation on Perioperative Functional Exercise Capacity in Patients Undergoing Colorectal Resection for Cancer: A Pilot Double-Blinded Randomized Placebo-Controlled Trial. J. Acad. Nutr. Diet. 2016, 116, 802–812. [Google Scholar] [CrossRef] [PubMed]
  64. Bauer, J.M.; Verlaan, S.; Bautmans, I.; Brandt, K.; Donini, L.M.; Maggio, M.; McMurdo, M.E.; Mets, T.; Seal, C.; Wijers, S.L.; et al. Effects of a vitamin D and leucine-enriched whey protein nutritional supplement on measures of sarcopenia in older adults, the PROVIDE study: A randomized, double-blind, placebo-controlled trial. J. Am. Med. Dir. Assoc. 2015, 16, 740–747. [Google Scholar] [CrossRef] [PubMed]
  65. Rondanelli, M.; Klersy, C.; Terracol, G.; Talluri, J.; Maugeri, R.; Guido, D.; Faliva, M.A.; Solerte, B.S.; Fioravanti, M.; Lukaski, H.; et al. Whey protein, amino acids, and vitamin D supplementation with physical activity increases fat-free mass and strength, functionality, and quality of life and decreases inflammation in sarcopenic elderly. Am. J. Clin. Nutr. 2016, 103, 830–840. [Google Scholar] [CrossRef] [PubMed]
  66. Prado, C.M.; Purcell, S.A.; Laviano, A. Nutrition interventions to treat low muscle mass in cancer. J. Cachexia Sarcopenia Muscle 2020, 11, 366–380. [Google Scholar] [CrossRef] [PubMed]
  67. Arena, R.; Myers, J.; Williams, M.A.; Gulati, M.; Kligfield, P.; Balady, G.J.; Collins, E.; Fletcher, G. Assessment of functional capacity in clinical and research settings: A scientific statement from the American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing. Circulation 2007, 116, 329–343. [Google Scholar] [PubMed]
  68. Gillis, C.; Ljungqvist, O.; Carli, F. Prehabilitation, enhanced recovery after surgery, or both? A narrative review. Br. J. Anaesth. 2022, 128, 434–448. [Google Scholar] [CrossRef] [PubMed]
  69. Bland, R.D.; Shoemaker, W.C.; Abraham, E.; Cobo, J.C. Hemodynamic and oxygen transport patterns in surviving and nonsurviving postoperative patients. Crit Care Med. 1985, 13, 85–90. [Google Scholar] [CrossRef]
  70. Veraar, C.; Fischer, A.; Bernardi, M.H.; Sulz, I.; Mouhieddine, M.; Dworschak, M.; Tschernko, E.; Lassnigg, A.; Hiesmayr, M. Absent Metabolic Transition from the Early to the Late Period in Non-Survivors Post Cardiac Surgery. Nutrients 2022, 14, 3366. [Google Scholar] [CrossRef] [PubMed]
  71. Stabenau, H.F.; Becher, R.D.; Gahbauer, E.A.; Leo-Summers, L.; Allore, H.G.; Gill, T.M. Functional Trajectories Before and After Major Surgery in Older Adults. Ann. Surg. 2018, 268, 911–917. [Google Scholar] [CrossRef] [PubMed]
  72. Marland, J.R.K.; Gray, M.E.; Argyle, D.J.; Underwood, I.; Murray, A.F.; Potter, M.A. Post-Operative Monitoring of Intestinal Tissue Oxygenation Using an Implantable Microfabricated Oxygen Sensor. Micromachines 2021, 12, 810. [Google Scholar] [CrossRef] [PubMed]
  73. Kwon, S.; Symons, R.; Yukawa, M.; Dasher, N.; Legner, V.; Flum, D.R. Evaluating the association of preoperative functional status and postoperative functional decline in older patients undergoing major surgery. Am. Surg. 2012, 78, 1336–1344. [Google Scholar] [CrossRef] [PubMed]
  74. Makker, P.G.S.; Koh, C.E.; Solomon, M.J.; Steffens, D. Preoperative functional capacity and postoperative outcomes following abdominal and pelvic cancer surgery: A systematic review and meta-analysis. ANZ J. Surg. 2022, 92, 1658–1667. [Google Scholar] [CrossRef] [PubMed]
  75. Otto, J.M.; O’Doherty, A.F.; Hennis, P.J.; Mitchell, K.; Pate, J.S.; Cooper, J.A.; Grocott, M.P.; Montgomery, H.E. Preoperative exercise capacity in adult inflammatory bowel disease sufferers, determined by cardiopulmonary exercise testing. Int. J. Color. Dis. 2012, 27, 1485–1491. [Google Scholar] [CrossRef] [PubMed]
  76. Stubbs, D.J.; Grimes, L.A.; Ercole, A. Performance of cardiopulmonary exercise testing for the prediction of post-operative complications in non cardiopulmonary surgery: A systematic review. PLoS ONE 2020, 15, e0226480. [Google Scholar] [CrossRef] [PubMed]
  77. Sarli, B.; Dogan, Y.; Poyrazoglu, O.; Baktir, A.O.; Eyvaz, A.; Altinkaya, E.; Tok, A.; Donudurmaci, E.; Ugurlu, M.; Ortakoyluoglu, A.; et al. Heart Rate Recovery Is Impaired in Patients with Inflammatory Bowel Diseases. Med. Princ. Pract. 2016, 25, 363–367. [Google Scholar] [CrossRef] [PubMed]
  78. Carli, F.; Baldini, G. From preoperative assessment to preoperative optimization of frail older patiens. Eur. J. Surg. Oncol. 2021, 47, 519–523. [Google Scholar] [CrossRef] [PubMed]
  79. Ferrandis, C.; Souche, R.; Bardol, T.; Boivineau, L.; Fabre, J.M.; Altwegg, R.; Guillon, F. Personalized pre-habilitation reduces anastomotic complications compared to up front surgery before ileocolic resection in high-risk patients with Crohn’s disease: A single center retrospective study. Int. J. Surg. 2022, 105, 106815. [Google Scholar] [CrossRef] [PubMed]
  80. Eagle, K.A.; Berger, P.B.; Calkins, H.; Chaitman, B.R.; Ewy, G.A.; Fleischmann, K.E.; Fleisher, L.A.; Froehlich, J.B.; Gusberg, R.J.; Leppo, J.A.; et al. ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery--Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth. Analg. 2002, 94, 1052–1064. [Google Scholar] [PubMed]
  81. Wijeysundera, D.N.; Pearse, R.M.; Shulman, M.A.; Abbott, T.E.F.; Torres, E.; Ambosta, A.; Croal, B.L.; Granton, J.T.; Thorpe, K.E.; Grocott, M.P.W.; et al. Assessment of functional capacity before major non-cardiac surgery: An international, prospective cohort study. Lancet 2018, 391, 2631–2640. [Google Scholar] [CrossRef] [PubMed]
  82. Lurati Buse, G.A.L.; Puelacher, C.; Gualandro, D.M.; Genini, A.S.; Hidvegi, R.; Bolliger, D.; Arslani, K.; Steiner, L.A.; Kindler, C.; Mueller, C. Association between self-reported functional capacity and major adverse cardiac events in patients at elevated risk undergoing noncardiac surgery: A prospective diagnostic cohort study. Br. J. Anaesth. 2021, 126, 102–110. [Google Scholar] [CrossRef]
  83. Hennis, P.J.; Meale, P.M.; Grocott, M.P. Cardiopulmonary exercise testing for the evaluation of perioperative risk in non-cardiopulmonary surgery. Postgrad. Med. J. 2011, 87, 550–557. [Google Scholar] [CrossRef] [PubMed]
  84. Alfitian, J.; Riedel, B.; Ismail, H.; Ho, K.M.; Xie, S.; Zimmer, P.; Kammerer, T.; Wijeysundera, D.N.; Cuthbertson, B.H.; Schier, R. Sex-related differences in functional capacity and its implications in risk stratification before major non-cardiac surgery: A post hoc analysis of the international METS study. EClinicalMedicine 2023, 64, 102223. [Google Scholar] [CrossRef] [PubMed]
  85. D’Ascenzi, F.; Cavigli, L.; Pagliaro, A.; Focardi, M.; Valente, S.; Cameli, M.; Mandoli, G.E.; Mueller, S.; Dendale, P.; Piepoli, M.; et al. Clinician approach to cardiopulmonary exercise testing for exercise prescription in patients at risk of and with cardiovascular disease. Br. J. Sports Med. 2022, 20, 1180–1187. [Google Scholar] [CrossRef] [PubMed]
  86. Allen, S.K.; Brown, V.; White, D.; King, D.; Hunt, J.; Wainwright, J.; Emery, A.; Hodge, E.; Kehinde, A.; Prabhu, P.; et al. Multimodal Prehabilitation During Neoadjuvant Therapy Prior to Esophagogastric Cancer Resection: Effect on Cardiopulmonary Exercise Test Performance, Muscle Mass and Quality of Life-A Pilot Randomized Clinical Trial. Ann. Surg. Oncol. 2022, 29, 1839–1850. [Google Scholar] [CrossRef] [PubMed]
  87. Huang, G.H.; Ismail, H.; Murnane, A.; Kim, P.; Riedel, B. Structured exercise program prior to major cancer surgery improves cardiopulmonary fitness: A retrospective cohort study. Support Care Cancer 2016, 24, 2277–2285. [Google Scholar] [CrossRef] [PubMed]
  88. Lee, L.; Schwartzman, K.; Carli, F.; Zavorsky, G.S.; Li, C.; Charlebois, P.; Stein, B.; Liberman, A.S.; Fried, G.M.; Feldman, L.S. The association of the distance walked in 6 min with pre-operative peak oxygen consumption and complications 1 month after colorectal resection. Anaesthesia 2013, 68, 811–816. [Google Scholar] [CrossRef] [PubMed]
  89. Singh, S.J.; Puhan, M.A.; Andrianopoulos, V.; Hernandes, N.A.; Mitchell, K.E.; Hill, C.J.; Lee, A.L.; Camillo, C.A.; Troosters, T.; Spruit, M.A.; et al. An official systematic review of the European Respiratory Society/American Thoracic Society: Measurement properties of field walking tests in chronic respiratory disease. Eur. Respir. J. 2014, 44, 1447–1478. [Google Scholar] [CrossRef] [PubMed]
  90. Ramos, R.J.; Ladha, K.S.; Cuthbertson, B.H.; Shulman, M.A.; Myles, P.S.; Wijeysundera, D.N. Association of six-minute walk test distance with postoperative complications in non-cardiac surgery: A secondary analysis of a multicentre prospective cohort study. Can. J. Anaesth. 2021, 68, 514–529. [Google Scholar] [CrossRef] [PubMed]
  91. Gillis, C.; Fenton, T.R.; Gramlich, L.; Sajobi, T.T.; Culos-Reed, S.N.; Bousquet-Dion, G.; Elsherbini, N.; Fiore, J.F., Jr.; Minnella, E.M.; Awasthi, R.; et al. Older frail prehabilitated patients who cannot attain a 400 m 6-min walking distance before colorectal surgery suffer more postoperative complications. Eur. J. Surg. Oncol. 2021, 47, 874–881. [Google Scholar] [CrossRef] [PubMed]
  92. Antonescu, I.; Scott, S.; Tran, T.T.; Mayo, N.E.; Feldman, L.S. Measuring postoperative recovery: What are clinically meaningful differences? Surgery 2014, 156, 319–327. [Google Scholar] [CrossRef] [PubMed]
  93. Struthers, R.; Erasmus, P.; Holmes, K.; Warman, P.; Collingwood, A.; Sneyd, J.R. Assessing fitness for surgery: A comparison of questionnaire, incremental shuttle walk, and cardiopulmonary exercise testing in general surgical patients. Br. J. Anaesth. 2008, 101, 774–780. [Google Scholar] [CrossRef] [PubMed]
  94. Wijeysundera, D.N.; Pearse, R.M.; Shulman, M.A.; Abbott, T.E.; Torres, E.; Croal, B.L.; Granton, J.T.; Thorpe, K.E.; Grocott, M.P.; Farrington, C.; et al. Measurement of Exercise Tolerance before Surgery (METS) study: A protocol for an international multicentre prospective cohort study of cardiopulmonary exercise testing prior to major non-cardiac surgery. BMJ Open 2016, 6, e010359. [Google Scholar] [CrossRef] [PubMed]
  95. Lurati Buse, G.A.; Mauermann, E.; Ionescu, D.; Szczeklik, W.; De Hert, S.; Filipovic, M.; Beck-Schimmer, B.; Spadaro, S.; Matute, P.; Bolliger, D.; et al. Risk assessment for major adverse cardiovascular events after noncardiac surgery using self-reported functional capacity: International prospective cohort study. Br. J. Anaesth. 2023, 130, 655–665. [Google Scholar] [CrossRef] [PubMed]
  96. Chouinard, G.; Roy, P.; Blais, M.C.; Lippens, A.; Pelletier, É.; Roy, E.; Marcoux, M.; Ugalde, P.A.; Rheault, J.; Pigeon, M.A.; et al. Exercise testing and postoperative complications after minimally invasive lung resection: A cohort study. Front. Physiol. 2022, 13, 951460. [Google Scholar] [CrossRef] [PubMed]
  97. Moyes, L.H.; McCaffer, C.J.; Carter, R.C.; Fullarton, G.M.; Mackay, C.K.; Forshaw, M.J. Cardiopulmonary exercise testing as a predictor of complications in oesophagogastric cancer surgery. Ann. R. Coll. Surg. Engl. 2013, 95, 125–130. [Google Scholar] [CrossRef] [PubMed]
  98. Moran, J.; Wilson, F.; Guinan, E.; McCormick, P.; Hussey, J.; Moriarty, J. Role of cardiopulmonary exercise testing as a risk-assessment method in patients undergoing intra-abdominal surgery: A systematic review. Br. J. Anaesth. 2016, 116, 177–191. [Google Scholar] [CrossRef] [PubMed]
  99. Silvapulle, E.; Darvall, J. Objective methods for preoperative assessment of functional capacity. BJA Educ. 2022, 22, 312–320. [Google Scholar] [CrossRef] [PubMed]
  100. Berkel, A.E.M.; Bongers, B.C.; Kotte, H.; Weltevreden, P.; de Jongh, F.H.C.; Eijsvogel, M.M.M.; Wymenga, M.; Bigirwamungu-Bargeman, M.; van der Palen, J.; van Det, M.J.; et al. Effects of Community-based Exercise Prehabilitation for Patients Scheduled for Colorectal Surgery with High Risk for Postoperative Complications: Results of a Randomized Clinical Trial. Ann. Surg. 2022, 275, e299–e306. [Google Scholar] [CrossRef] [PubMed]
  101. Michel, A.; Gremeaux, V.; Muff, G.; Pache, B.; Geinoz, S.; Larcinese, A.; Benaim, C.; Kayser, B.; Demartines, N.; Hübner, M.; et al. Short term high-intensity interval training in patients scheduled for major abdominal surgery increases aerobic fitness. BMC Sports Sci. Med. Rehabil. 2022, 14, 61. [Google Scholar] [CrossRef] [PubMed]
  102. Sinclair, R.C.; Batterham, A.M.; Davies, S.; Cawthorn, L.; Danjoux, G.R. Validity of the 6 min walk test in prediction of the anaerobic threshold before major non-cardiac surgery. Br. J. Anaesth. 2012, 108, 30–35. [Google Scholar] [CrossRef] [PubMed]
  103. Riedel, B.; Li, M.H.; Lee, C.H.A.; Ismail, H.; Cuthbertson, B.H.; Wijeysundera, D.N.; Ho, K.M. A simplified (modified) Duke Activity Status Index (M-DASI) to characterise functional capacity: A secondary analysis of the Measurement of Exercise Tolerance before Surgery (METS) study. Br. J. Anaesth. 2021, 126, 181–190. [Google Scholar] [CrossRef] [PubMed]
  104. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: Guidelines for the six-minute walk test. Am. J. Respir. Crit Care Med. 2002, 166, 111–117. [Google Scholar] [CrossRef] [PubMed]
  105. Minnella, E.M.; Liberman, A.S.; Charlebois, P.; Stein, B.; Scheede-Bergdahl, C.; Awasthi, R.; Gillis, C.; Bousquet-Dion, G.; Ramanakuma, A.V.; Pecorelli, N.; et al. The impact of improved functional capacity before surgery on postoperative complications: A study in colorectal cancer. Acta Oncol. 2019, 58, 573–578. [Google Scholar] [CrossRef] [PubMed]
  106. Dolecińska, D.; Przywarska, I.; Podgórski, T.; Dylewicz, P.; Lewandowski, J. Use of the six-minute walk test in exercise prescription in male patients after coronary artery bypass surgery. Kardiochir. Torakochirurgia Pol. 2020, 17, 183–188. [Google Scholar] [CrossRef] [PubMed]
  107. Garnacho-Castaño, M.V.; Domínguez, R.; Muñoz González, A.; Feliu-Ruano, R.; Serra-Payá, N.; Maté-Muñoz, J.L. Exercise Prescription Using the Borg Rating of Perceived Exertion to Improve Fitness. Int. J. Sports Med. 2018, 39, 115–123. [Google Scholar] [CrossRef] [PubMed]
  108. Hlatky, M.A.; Boineau, R.E.; Higginbotham, M.B.; Lee, K.L.; Mark, D.B.; Califf, R.M.; Cobb, F.R.; Pryor, D.B. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am. J. Cardiol. 1989, 64, 651–654. [Google Scholar] [CrossRef] [PubMed]
  109. Wijeysundera, D.N.; Beattie, W.S.; Hillis, G.S.; Abbott, T.E.F.; Shulman, M.A.; Ackland, G.L.; Mazer, C.D.; Myles, P.S.; Pearse, R.M.; Cuthbertson, B.H.; et al. Integration of the Duke Activity Status Index into preoperative risk evaluation: A multicentre prospective cohort study. Br. J. Anaesth. 2020, 124, 261–270. [Google Scholar] [CrossRef] [PubMed]
  110. Shulman, M.A.; Cuthbertson, B.H.; Wijeysundera, D.N.; Pearse, R.M.; Thompson, B.; Torres, E.; Ambosta, A.; Wallace, S.; Farrington, C.; Myles, P.S. Using the 6-minute walk test to predict disability-free survival after major surgery. Br. J. Anaesth. 2019, 122, 111–119. [Google Scholar] [CrossRef] [PubMed]
  111. Argillander, T.E.; van der Zanden, V.; van der Zaag-Loonen, H.J.; Paarlberg, K.M.; Meijer, W.J.; Kruse, A.-J.; van Westreenen, H.L.; van Duijvendijk, P.; Mourits, M.J.E.; van Munster, B.C. Preoperative physical activity and frailty in older patients undergoing cancer surgery–PREsurgery study. J. Geriatr. Oncol. 2022, 13, 384–387. [Google Scholar] [CrossRef] [PubMed]
  112. Beltz, S.; Gloystein, S.; Litschko, T.; Laag, S.; van den Berg, N. Multivariate analysis of independent determinants of ADL/IADL and quality of life in the elderly. BMC Geriatr. 2022, 22, 894. [Google Scholar] [CrossRef] [PubMed]
  113. Gobbens, R.J.; van Assen, M.A. The Prediction of ADL and IADL Disability Using Six Physical Indicators of Frailty: A Longitudinal Study in the Netherlands. Curr. Gerontol. Geriatr. Res. 2014, 2014, 358137. [Google Scholar] [CrossRef] [PubMed]
  114. Ligthart-Melis, G.C.; Luiking, Y.C.; Kakourou, A.; Cederholm, T.; Maier, A.B.; de van der Schueren, M.A.E. Frailty, Sarcopenia, and Malnutrition Frequently (Co-)occur in Hospitalized Older Adults: A Systematic Review and Meta-analysis. J. Am. Med. Dir. Assoc. 2020, 21, 1216–1228. [Google Scholar] [CrossRef] [PubMed]
  115. Faye, A.S.; Colombel, J.F. Aging and IBD: A New Challenge for Clinicians and Researchers. Inflamm. Bowel Dis. 2022, 28, 126–132. [Google Scholar] [CrossRef] [PubMed]
  116. Panayi, A.C.; Orkaby, A.R.; Sakthivel, D.; Endo, Y.; Varon, D.; Roh, D.; Orgill, D.P.; Neppl, R.L.; Javedan, H.; Bhasin, S.; et al. Impact of frailty on outcomes in surgical patients: A systematic review and meta-analysis. Am. J. Surg. 2019, 218, 393–400. [Google Scholar] [CrossRef] [PubMed]
  117. Park, B.; Bhat, S.; Xia, W.; Barazanchi, A.W.H.; Frampton, C.; Hill, A.G.; MacCormick, A.D. Consensus-defined sarcopenia predicts adverse outcomes after elective abdominal surgery: Meta-analysis. BJS Open 2023, 7, zrad065. [Google Scholar] [CrossRef] [PubMed]
  118. Chen, L.K.; Woo, J.; Assantachai, P.; Auyeung, T.W.; Chou, M.Y.; Iijima, K.; Jang, H.C.; Kang, L.; Kim, M.; Kim, S.; et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J. Am. Med. Dir. Assoc. 2020, 21, 300–307.e2. [Google Scholar] [CrossRef] [PubMed]
  119. Jung, H.W.; Baek, J.Y.; Jang, I.Y.; Guralnik, J.M.; Rockwood, K.; Lee, E.; Kim, D.H. Short Physical Performance Battery as a Crosswalk Between Frailty Phenotype and Deficit Accumulation Frailty Index. J. Gerontol. A Biol. Sci. Med. Sci. 2021, 76, 2249–2255. [Google Scholar] [CrossRef] [PubMed]
  120. Jung, H.W.; Kim, S.; Jang, I.Y.; Shin, D.W.; Lee, J.E.; Won, C.W. Screening Value of Timed Up and Go Test for Frailty and Low Physical Performance in Korean Older Population: The Korean Frailty and Aging Cohort Study (KFACS). Ann. Geriatr. Med. Res. 2020, 24, 259–266. [Google Scholar] [CrossRef]
  121. McIsaac, D.I.; MacDonald, D.B.; Aucoin, S.D. Frailty for Perioperative Clinicians: A Narrative Review. Anesth. Analg. 2020, 130, 1450–1460. [Google Scholar] [CrossRef] [PubMed]
  122. Fatani, H.; Olaru, A.; Stevenson, R.; Alharazi, W.; Jafer, A.; Atherton, P.; Brook, M.; Moran, G. Systematic review of sarcopenia in inflammatory bowel disease. Clin. Nutr. 2023, 42, 1276–1291. [Google Scholar] [CrossRef] [PubMed]
  123. Huang, X.; Xiao, M.; Jiang, B.; Wang, X.; Tang, X.; Xu, X.; Chen, Y.; Wang, S.; Yan, S.; Wang, S.; et al. Prevalence of frailty among patients with inflammatory bowel disease and its association with clinical outcomes: A systematic review and meta-analysis. BMC Gastroenterol. 2022, 22, 534. [Google Scholar] [CrossRef] [PubMed]
  124. Rajarajeswaran, P.; Vishnupriya, R. Exercise in cancer. Indian J. Med. Paediatr. Oncol. 2009, 30, 61–70. [Google Scholar] [CrossRef] [PubMed]
  125. Pescatello, L.S.; Arena, R.; Riebe, D.; Thompson, P.D. ACSM’s Guidelines for Exercise Testing and Prescription, 9th ed.; Wolters Kluwer/Lippincott Williams & Wilkins Health: Philadelphia, PA, USA, 2014. [Google Scholar]
  126. Minnella, E.M.; Ferreira, V.; Awasthi, R.; Charlebois, P.; Stein, B.; Liberman, A.S.; Scheede-Bergdahl, C.; Morais, J.A.; Carli, F. Effect of two different pre-operative exercise training regimens before colorectal surgery on functional capacity: A randomised controlled trial. Eur. J. Anaesthesiol. 2020, 37, 969–978. [Google Scholar] [CrossRef] [PubMed]
  127. Li, C.; Carli, F.; Lee, L.; Charlebois, P.; Stein, B.; Liberman, A.S.; Kaneva, P.; Augustin, B.; Wongyingsinn, M.; Gamsa, A.; et al. Impact of a trimodal prehabilitation program on functional recovery after colorectal cancer surgery: A pilot study. Surg. Endosc. 2013, 27, 1072–1082. [Google Scholar] [CrossRef] [PubMed]
  128. Licker, M.; Karenovics, W.; Diaper, J.; Frésard, I.; Triponez, F.; Ellenberger, C.; Schorer, R.; Kayser, B.; Bridevaux, P.O. Short-Term Preoperative High-Intensity Interval Training in Patients Awaiting Lung Cancer Surgery: A Randomized Controlled Trial. J. Thorac. Oncol. 2017, 12, 323–333. [Google Scholar] [CrossRef] [PubMed]
  129. Weston, K.S.; Wisløff, U.; Coombes, J.S. High-intensity interval training in patients with lifestyle-induced cardiometabolic disease: A systematic review and meta-analysis. Br. J. Sports Med. 2014, 48, 1227–1234. [Google Scholar] [CrossRef]
  130. Edwards, J.; Shanmugam, N.; Ray, R.; Jouhra, F.; Mancio, J.; Wiles, J.; Marciniak, A.; Sharma, R.; O’Driscoll, J. Exercise Mode in Heart Failure: A Systematic Review and Meta-Analysis. Sports Med.-Open 2023, 9, 3. [Google Scholar] [CrossRef] [PubMed]
  131. Richardson, K.; Levett, D.Z.H.; Jack, S.; Grocott, M.P.W. Fit for surgery? Perspectives on preoperative exercise testing and training. Br. J. Anaesth. 2017, 119 (Suppl. 1), i34–i43. [Google Scholar] [CrossRef] [PubMed]
  132. Minnella, E.M.; Carli, F. Prehabilitation and functional recovery for colorectal cancer patients. Eur. J. Surg. Oncol. 2018, 44, 919–926. [Google Scholar] [CrossRef] [PubMed]
  133. Wilkinson, S.B.; Tarnopolsky, M.A.; Macdonald, M.J.; Macdonald, J.R.; Armstrong, D.; Phillips, S.M. Consumption of fluid skim milk promotes greater muscle protein accretion after resistance exercise than does consumption of an isonitrogenous and isoenergetic soy-protein beverage. Am. J. Clin. Nutr. 2007, 85, 1031–1040. [Google Scholar] [CrossRef] [PubMed]
  134. Awasthi, R.; Minnella, E.M.; Ferreira, V.; Ramanakumar, A.V.; Scheede-Bergdahl, C.; Carli, F. Supervised exercise training with multimodal pre-habilitation leads to earlier functional recovery following colorectal cancer resection. Acta Anaesthesiol. Scand. 2019, 63, 461–467. [Google Scholar] [CrossRef] [PubMed]
  135. Ferreira, V.; Agnihotram, R.V.; Bergdahl, A.; van Rooijen, S.J.; Awasthi, R.; Carli, F.; Scheede-Bergdahl, C. Maximizing patient adherence to prehabilitation: What do the patients say? Support Care Cancer 2018, 26, 2717–2723. [Google Scholar] [CrossRef]
  136. Blumenau Pedersen, M.; Saxton, J.; Birch, S.; Rasmussen Villumsen, B.; Bjerggaard Jensen, J. The use of digital technologies to support home-based prehabilitation prior to major surgery: A systematic review. Surgeon 2023, 21, e305–e315. [Google Scholar] [CrossRef] [PubMed]
  137. Katsura, M.; Kuriyama, A.; Takeshima, T.; Fukuhara, S.; Furukawa, T.A. Preoperative inspiratory muscle training for postoperative pulmonary complications in adults undergoing cardiac and major abdominal surgery. Cochrane Database Syst. Rev. 2015, 2015, Cd010356. [Google Scholar] [CrossRef] [PubMed]
  138. Taskin, H.; Telli Atalay, O.; Gür Kabul, E.; Basakcı Calik, B.; Yıldız, A.; Aslan, U.; Taşçı, M.; Bıçakcı, F. The effects of inspiratory muscle training on aerobic capacity, pulmonary functions and functional status in patients with ankylosing spondylitis. Eur. Respir. J. 2017, 50, PA3283. [Google Scholar]
  139. Lumb, A.B. Pre-operative respiratory optimisation: An expert review. Anaesthesia 2019, 74, 43–48. [Google Scholar] [CrossRef] [PubMed]
  140. Meima-van Praag, E.M.; Buskens, C.J.; Hompes, R.; Bemelman, W.A. Surgical management of Crohn’s disease: A state of the art review. Int. J. Color. Dis. 2021, 36, 1133–1145. [Google Scholar] [CrossRef] [PubMed]
  141. Hanalis-Miller, T.; Nudelman, G.; Ben-Eliyahu, S.; Jacoby, R. The Effect of Pre-operative Psychological Interventions on Psychological, Physiological, and Immunological Indices in Oncology Patients: A Scoping Review. Front. Psychol. 2022, 13, 839065. [Google Scholar] [CrossRef] [PubMed]
  142. Gomes, E.T.; Galvão, P.C.d.C.; dos Santos, K.V.; Bezerra, S.M.M.d.S. Risk factors for anxiety and depression in the preoperative period of cardiac surgery. Enfermería Glob. 2019, 18, 426–469. [Google Scholar] [CrossRef]
  143. Graff, L.A.; Walker, J.R.; Bernstein, C.N. Depression and anxiety in inflammatory bowel disease: A review of comorbidity and management. Inflamm. Bowel Dis. 2009, 15, 1105–1118. [Google Scholar] [CrossRef] [PubMed]
  144. Linnen, H.; Krampe, H.; Neumann, T.; Wei-Gerlach, E.; Heinz, A.; Wernecke, K.D.; Spies, C.D. Depression and essential health risk factors in surgical patients in the preoperative anaesthesiological assessment clinic. Eur. J. Anaesthesiol. 2011, 28, 733–741. [Google Scholar] [CrossRef] [PubMed]
  145. Mardini, H.E.; Kip, K.E.; Wilson, J.W. Crohn’ disease: A two-year prospective study of the association between psychological distress and disease activity. Dig. Dis. Sci. 2004, 49, 492–497. [Google Scholar] [CrossRef] [PubMed]
  146. Romanazzo, S.; Mansueto, G.; Cosci, F. Anxiety in the Medically Ill: A Systematic Review of the Literature. Front. Psychiatry 2022, 13, 873126. [Google Scholar] [CrossRef] [PubMed]
  147. Sinikallio, S.; Aalto, T.; Airaksinen, O.; Herno, A.; Kröger, H.; Viinamäki, H. Depressive burden in the preoperative and early recovery phase predicts poorer surgery outcome among lumbar spinal stenosis patients: A one-year prospective follow-up study. Spine 2009, 34, 2573–2578. [Google Scholar] [CrossRef] [PubMed]
  148. Van Assche, G.; Dignass, A.; Reinisch, W.; van der Woude, C.J.; Sturm, A.; De Vos, M.; Guslandi, M.; Oldenburg, B.; Dotan, I.; Marteau, P.; et al. The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: Special situations. J. Crohn’s Colitis 2010, 4, 63–101. [Google Scholar] [CrossRef] [PubMed]
  149. Bak, M.T.J.; Ruiterkamp, M.F.E.; van Ruler, O.; Campmans-Kuijpers, M.J.E.; Bongers, B.C.; van Meeteren, N.L.U.; van der Woude, C.J.; Stassen, L.P.S.; de Vries, A.C. Prehabilitation prior to intestinal resection in Crohn’s disease patients: An opinion review. World J. Gastroenterol. 2022, 28, 2403–2416. [Google Scholar] [CrossRef] [PubMed]
  150. Britteon, P.; Cullum, N.; Sutton, M. Association between psychological health and wound complications after surgery. Br. J. Surg. 2017, 104, 769–776. [Google Scholar] [CrossRef] [PubMed]
  151. Lenze, E.J.; Rogers, J.C.; Martire, L.M.; Mulsant, B.H.; Rollman, B.L.; Dew, M.A.; Schulz, R.; Reynolds, C.F., 3rd. The association of late-life depression and anxiety with physical disability: A review of the literature and prospectus for future research. Am. J. Geriatr. Psychiatry 2001, 9, 113–135. [Google Scholar] [CrossRef] [PubMed]
  152. Mittermaier, C.; Dejaco, C.; Waldhoer, T.; Oefferlbauer-Ernst, A.; Miehsler, W.; Beier, M.; Tillinger, W.; Gangl, A.; Moser, G. Impact of depressive mood on relapse in patients with inflammatory bowel disease: A prospective 18-month follow-up study. Psychosom. Med. 2004, 66, 79–84. [Google Scholar] [CrossRef] [PubMed]
  153. Wang, R.; Huang, X.; Wang, Y.; Akbari, M. Non-pharmacologic Approaches in Preoperative Anxiety, a Comprehensive Review. Front. Public Health 2022, 10, 854673. [Google Scholar] [CrossRef] [PubMed]
  154. Ringel, Y.; Drossman, D.A. Psychosocial aspects of Crohn’s disease. Surg. Clin. N. Am. 2001, 81, 231–252. [Google Scholar] [CrossRef] [PubMed]
  155. Cosci, F. Clinimetric Perspectives in Clinical Psychology and Psychiatry. Psychother. Psychosom. 2021, 90, 217–221. [Google Scholar] [CrossRef] [PubMed]
  156. Fava, G.A.; Cosci, F.; Sonino, N. Current Psychosomatic Practice. Psychother. Psychosom. 2017, 86, 13–30. [Google Scholar] [CrossRef] [PubMed]
  157. Mystakidou, K.; Tsilika, E.; Parpa, E.; Athanasouli, P.; Galanos, A.; Anna, P.; Vlahos, L. Illness-related hopelessness in advanced cancer: Influence of anxiety, depression, and preparatory grief. Arch. Psychiatr. Nurs. 2009, 23, 138–147. [Google Scholar] [CrossRef] [PubMed]
  158. Fava, G.A.; Tomba, E.; Brakemeier, E.L.; Carrozzino, D.; Cosci, F.; Eöry, A.; Leonardi, T.; Schamong, I.; Guidi, J. Mental Pain as a Transdiagnostic Patient-Reported Outcome Measure. Psychother. Psychosom. 2019, 88, 341–349. [Google Scholar] [CrossRef] [PubMed]
  159. Francis, J.J.; Wileman, S.M.; Bekker, H.; Barton, G.R.; Ramsay, C.R. Beliefs about surgery: Development and validation of an instrument to assess cognitive representations about surgery, in the context of a chronic illness. Psychol. Health 2009, 24, 1125–1137. [Google Scholar] [CrossRef] [PubMed]
  160. Cosci, F.; Fava, G.A. The clinical inadequacy of the DSM-5 classification of somatic symptom and related disorders: An alternative trans-diagnostic model. CNS Spectr. 2016, 21, 310–317. [Google Scholar] [CrossRef] [PubMed]
  161. Cosci, F.; Fava, G.A.; Sonino, N. Mood and anxiety disorders as early manifestations of medical illness: A systematic review. Psychother. Psychosom. 2015, 84, 22–29. [Google Scholar] [CrossRef] [PubMed]
  162. Cassem, E.H. Depression and anxiety secondary to medical illness. Psychiatr. Clin. N. Am. 1990, 13, 597–612. [Google Scholar] [CrossRef]
  163. Ryff, C.D. Psychological well-being revisited: Advances in the science and practice of eudaimonia. Psychother. Psychosom. 2014, 83, 10–28. [Google Scholar] [CrossRef] [PubMed]
  164. Topp, C.W.; Østergaard, S.D.; Søndergaard, S.; Bech, P. The WHO-5 Well-Being Index: A systematic review of the literature. Psychother. Psychosom. 2015, 84, 167–176. [Google Scholar] [CrossRef] [PubMed]
  165. Silver, J.K.; Baima, J. Cancer prehabilitation: An opportunity to decrease treatment-related morbidity, increase cancer treatment options, and improve physical and psychological health outcomes. Am. J. Phys. Med. Rehabil. 2013, 92, 715–727. [Google Scholar] [CrossRef] [PubMed]
  166. Dao, T.K.; Youssef, N.A.; Armsworth, M.; Wear, E.; Papathopoulos, K.N.; Gopaldas, R. Randomized controlled trial of brief cognitive behavioral intervention for depression and anxiety symptoms preoperatively in patients undergoing coronary artery bypass graft surgery. J. Thorac. Cardiovasc. Surg. 2011, 142, e109–e115. [Google Scholar] [CrossRef] [PubMed]
  167. Knowles, S.R.; Monshat, K.; Castle, D.J. The efficacy and methodological challenges of psychotherapy for adults with inflammatory bowel disease: A review. Inflamm. Bowel Dis. 2013, 19, 2704–2715. [Google Scholar] [CrossRef] [PubMed]
  168. Beck, A.T. Cognitive Therapy and the Emotional Disorders, 1st ed.; Penguin: London, UK, 1979. [Google Scholar]
  169. Gregory, V.L. Cognitive-behavioral therapy for adults with inflammatory bowel disease: A meta-analysis of randomized controlled trials with implications for clinical social work. J. Evid.-Based Soc. Work. 2019, 16, 363–385. [Google Scholar] [CrossRef]
  170. Fava, G.A. Well-Being Therapy: Treatment Manual and Clinical Applications; Karger: Basel, Switzerland, 2016. [Google Scholar]
  171. Fava, G.A. Well-Being Therapy: Current Indications and Emerging Perspectives. Psychother. Psychosom. 2016, 85, 136–145. [Google Scholar] [CrossRef]
  172. Benasi, G.; Gostoli, S.; Zhu, B.; Offidani, E.; Artin, M.G.; Gagliardi, L.; Rignanese, G.; Sassi, G.; Fava, G.A.; Rafanelli, C. Well-Being Therapy and Lifestyle Intervention in Type 2 Diabetes: A Pilot Randomized Controlled Trial. Psychosom. Med. 2022, 84, 1041–1049. [Google Scholar] [CrossRef] [PubMed]
  173. Mansueto, G.; Cosci, F. Well-Being Therapy for Depressive Symptoms in Chronic Migraine: A Case Report. Clin. Case Stud. 2021, 20, 296–309. [Google Scholar] [CrossRef]
  174. Rafanelli, C.; Gostoli, S.; Buzzichelli, S.; Guidi, J.; Sirri, L.; Gallo, P.; Marzola, E.; Bergerone, S.; De Ferrari, G.M.; Roncuzzi, R.; et al. Sequential Combination of Cognitive-Behavioral Treatment and Well-Being Therapy in Depressed Patients with Acute Coronary Syndromes: A Randomized Controlled Trial (TREATED-ACS Study). Psychother. Psychosom. 2020, 89, 345–356. [Google Scholar] [CrossRef] [PubMed]
  175. Romanazzo, S.; Ceccatelli, S.; Mansueto, G.; Sera, F.; Guiducci, S.; Matucci Cerinic, M.; Cosci, F. Well-Being Therapy in systemic sclerosis outpatients: A randomized controlled trial. Rheumatology 2024, keae114. [Google Scholar] [CrossRef] [PubMed]
  176. Musallam, K.M.; Tamim, H.M.; Richards, T.; Spahn, D.R.; Rosendaal, F.R.; Habbal, A.; Khreiss, M.; Dahdaleh, F.S.; Khavandi, K.; Sfeir, P.M.; et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: A retrospective cohort study. Lancet 2011, 378, 1396–1407. [Google Scholar] [CrossRef] [PubMed]
  177. Talboom, K.; Borstlap, W.A.A.; Roodbeen, S.X.; Bruns, E.R.J.; Buskens, C.J.; Hompes, R.; Tytgat, K.; Tuynman, J.B.; Consten, E.C.J.; Heuff, G.; et al. Ferric carboxymaltose infusion versus oral iron supplementation for preoperative iron deficiency anaemia in patients with colorectal cancer (FIT): A multicentre, open-label, randomised, controlled trial. Lancet Haematol. 2023, 10, e250–e260. [Google Scholar] [CrossRef] [PubMed]
  178. Duggan, E.W.; Carlson, K.; Umpierrez, G.E.J.A. Perioperative hyperglycemia management: An update. Anesthesiology 2017, 126, 547–560. [Google Scholar] [CrossRef]
  179. Barnes, E.L.; Lightner, A.L.; Regueiro, M. Perioperative and Postoperative Management of Patients with Crohn’s Disease and Ulcerative Colitis. Clin. Gastroenterol. Hepatol. 2020, 18, 1356–1366. [Google Scholar] [CrossRef] [PubMed]
  180. Bower, J.A.J.; O’Flynn, L.; Kakad, R.; Aldulaimi, D. Effect of inflammatory bowel disease treatments on patients with diabetes mellitus. World J. Diabetes 2021, 12, 1248–1254. [Google Scholar] [CrossRef] [PubMed]
  181. Groleau, C.; Morin, S.N.; Vautour, L.; Amar-Zifkin, A.; Bessissow, A. Perioperative corticosteroid administration: A systematic review and descriptive analysis. Perioper. Med. 2018, 7, 10. [Google Scholar] [CrossRef] [PubMed]
  182. McIsaac, D.I.; Gill, M.; Boland, L.; Hutton, B.; Branje, K.; Shaw, J.; Grudzinski, A.L.; Barone, N.; Gillis, C. Prehabilitation in adult patients undergoing surgery: An umbrella review of systematic reviews. Br. J. Anaesth. 2022, 128, 244–257. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Objectives of perioperative nutritional interventions in patients with inflammatory bowel disease.
Figure 1. Objectives of perioperative nutritional interventions in patients with inflammatory bowel disease.
Nutrients 16 01783 g001
Figure 2. Proposed assessment and therapeutic approaches to preoperative psychological distress: A patient with Crohn’s disease reporting disruptive beliefs about surgery, psychological distress, depressive and anxious symptoms, and poor well-being. The therapist could give priority to cognitive behavioural therapy (CBT) to identify and restructuring disruptive beliefs on surgery in order to reduce psychological distress, depressive and anxious symptoms. Then, the therapist could decide to improve well-being via Well-Being Therapy (WBT) techniques.
Figure 2. Proposed assessment and therapeutic approaches to preoperative psychological distress: A patient with Crohn’s disease reporting disruptive beliefs about surgery, psychological distress, depressive and anxious symptoms, and poor well-being. The therapist could give priority to cognitive behavioural therapy (CBT) to identify and restructuring disruptive beliefs on surgery in order to reduce psychological distress, depressive and anxious symptoms. Then, the therapist could decide to improve well-being via Well-Being Therapy (WBT) techniques.
Nutrients 16 01783 g002
Table 1. Preoperative nutritional screening and assessment.
Table 1. Preoperative nutritional screening and assessment.
Preoperative malnutrition ScreeningMUST
NRS-2002
MIRT
SaskIBD-NR
NS-IBD
Preoperative malnutrition assessment and diagnosis toolGLIM Criteria
Preoperative sarcopenia assessmentBody composition
Muscle Strength (Hand Grip, 5-time chair standing test)
Functional assessment (walking tests, gait speed, SPPB, TUG)
Anaemia: screening and assessment ofComplete blood count
Serum ferritin, transferrin, C-reactive protein, Vitamin B12, Folates, Creatinine
Micronutrient assessmentVitamin B12, Vitamin D, Folic acid
Legend: MUST = Malnutrition Universal Screening Tool; NRS-2002 = Nutrition Risk Screening 2002; MIRT = Malnutrition Inflammation Risk Tool; SaskIBD-NR = Saskatchewan IBD Nutrition Risk Tool; NS-IBD = Inflammatory Bowel Disease-Nutritional Screening tool; GLIM = Global Leadership Initiative on Malnutrition; SPPB = Short Physical Performance Battery; TUG = Timed Up and Go.
Table 2. Predicted Outcomes and Utility of common tools used to measure or estimate preoperative functional capacity in the context of a prehabilitation program.
Table 2. Predicted Outcomes and Utility of common tools used to measure or estimate preoperative functional capacity in the context of a prehabilitation program.
Predicted Outcomes and Utility in the Context of a Prehabilitation Program
Measurement/Evaluation of Functional CapacityPredicted Postoperative OutcomesUtility in the Context of a Prehabilitation Program
Cardio-Pulmonary Exercise Testing (CPET)Gold Standard for measuring cardiopulmonary and musculoskeletal efficiency [83]

Measures: VO2-peak, VO2-AT, VE/VCO2,
O2 pulse [83]
VO2-Peak: predicts moderate or severe postoperative complications. [84]

VO2-AT: high negative predictive values (94–100%) for postoperative mortality [76]
Tailored exercise prescription [85]

Evaluating preoperative therapies in cancer surgery [86]

Prehabilitation response and risk stratification [87]
6-Minute Walking Test (6MWT)Submaximal exercise test
Moderate correlation with VO2-peak [88,89]
Modest association with moderate or severe complications [90]Prehabilitation response and risk stratification [14]

Attaining a 6MWD < 400 m after prehabilitation: higher risk of 30-day postoperative complications [91]

Clinically meaningful 6MWD change: ≥20 m [92]
Duke Activity Status Index (DASI)Modest correlation between the DASI score and VO2-peak [93]

Moderate ability to predict VO2-peak > 15 mL/kg/min [93]
30-day death, MINS, MI, moderate-to-severe complications, and new disability [94]
Subjective assessment of Metabolic Equivalents (METs)Low sensitivity for identifying patients with poor functional capacity [81]Predicts MACE in high-cardiovascular risk population [82]

Does not improve MACEs prediction compared with clinical risk factors [95]
-
Legend: MINS = myocardial injury after non-cardiac surgery; MI = myocardial infarction; MACEs = major adverse cardiovascular events; VO2-peak = peak oxygen uptake; VO2-AT = oxygen consumption at the anaerobic threshold; VE/VCO2 = Ventilatory equivalent for CO2; 6MWD = 6-minute walking distance.
Table 3. Example of Prehabilitation exercise training program based on FITT-VP principles [125].
Table 3. Example of Prehabilitation exercise training program based on FITT-VP principles [125].
FITT-VP Exercise Prescription
Aerobic TrainingResistance Training
HIITMICT
FrequencyThree times per week (at least 4 weeks)Three times per week (at least 4 weeks)Three times per week (at least 4 weeks)
Intensity85–90% VO2-peak
Active recovery: 80–85% VO2AT
80–85% VO2 AT60–80% of 1RM
Time34 min (including 5 min of warm-up and 5 min of recovery)40 min30 min
TypeCycle ergometer, treadmill, NuStepCycle ergometer, treadmill, NuStepDumbbell, elastic band, stick, med ball
Volume4 repetitions of high intensity (3 min) with active rest (4 min)Continuous3 progressive sets (e.g., 10 × 3, 12 × 3, 15 × 3) of upper, lower, total body and abdominals
ProgressionMonthly cyclesMonthly cyclesWeekly cycles
Legend: VO2 = Oxygen Uptake; AT = Anaerobic Threshold; HIIT = High Intensity Interval Training; MICT = Moderate Intensity Continuous Training; 1RM = one-repetition maximum test.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Fiorindi, C.; Giudici, F.; Testa, G.D.; Foti, L.; Romanazzo, S.; Tognozzi, C.; Mansueto, G.; Scaringi, S.; Cuffaro, F.; Nannoni, A.; et al. Multimodal Prehabilitation for Patients with Crohn’s Disease Scheduled for Major Surgery: A Narrative Review. Nutrients 2024, 16, 1783. https://doi.org/10.3390/nu16111783

AMA Style

Fiorindi C, Giudici F, Testa GD, Foti L, Romanazzo S, Tognozzi C, Mansueto G, Scaringi S, Cuffaro F, Nannoni A, et al. Multimodal Prehabilitation for Patients with Crohn’s Disease Scheduled for Major Surgery: A Narrative Review. Nutrients. 2024; 16(11):1783. https://doi.org/10.3390/nu16111783

Chicago/Turabian Style

Fiorindi, Camilla, Francesco Giudici, Giuseppe Dario Testa, Lorenzo Foti, Sara Romanazzo, Cristina Tognozzi, Giovanni Mansueto, Stefano Scaringi, Francesca Cuffaro, Anita Nannoni, and et al. 2024. "Multimodal Prehabilitation for Patients with Crohn’s Disease Scheduled for Major Surgery: A Narrative Review" Nutrients 16, no. 11: 1783. https://doi.org/10.3390/nu16111783

APA Style

Fiorindi, C., Giudici, F., Testa, G. D., Foti, L., Romanazzo, S., Tognozzi, C., Mansueto, G., Scaringi, S., Cuffaro, F., Nannoni, A., Soop, M., & Baldini, G. (2024). Multimodal Prehabilitation for Patients with Crohn’s Disease Scheduled for Major Surgery: A Narrative Review. Nutrients, 16(11), 1783. https://doi.org/10.3390/nu16111783

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop